data_1j7p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1j7p _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.27 -43.47 81.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.303 -0.873 . . . . 1.0 109.524 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.56 ' CG ' HH11 ' A' ' 86' ' ' ARG . 0.4 OUTLIER -65.08 -50.39 66.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 1.0 109.362 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -58.26 -44.96 88.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.878 -1.139 . . . . 1.0 108.412 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.61 97.62 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -62.9 -40.22 96.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.027 -1.045 . . . . 1.0 109.279 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.585 HH21 ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -69.72 -32.74 71.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.937 -1.102 . . . . 1.0 108.996 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.46 -36.69 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.949 . . . . 1.0 109.879 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -79.76 -25.93 40.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.966 -1.084 . . . . 1.0 109.606 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 98' ' ' GLY . 53.8 t0 -79.74 74.26 6.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 1.0 108.556 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' NZ ' ' CG2' ' A' ' 108' ' ' VAL . 12.1 mptt -54.14 -38.74 65.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.873 -0.517 . . . . 1.0 110.798 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 9.4 p30 -88.31 -4.9 58.61 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.121 -0.987 . . . . 1.0 110.952 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.585 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . 67.63 23.1 73.78 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.599 -1.286 . . . . 1.0 110.187 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.486 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 50.5 p-10 -76.69 -3.06 36.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -1.14 . . . . 1.0 110.73 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.433 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 79.34 5.17 89.24 Favored Glycine 0 N--CA 1.489 2.193 0 O-C-N 120.591 -1.318 . . . . 1.0 110.538 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 31.3 m-85 -139.44 138.84 36.8 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.303 -1.116 . . . . 1.0 109.822 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.0 mt -96.31 122.24 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 1.0 109.06 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 t -84.78 158.97 20.55 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.509 0.671 . . . . 1.0 109.575 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.71 90.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.342 -0.849 . . . . 1.0 109.698 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.53 -33.65 76.06 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.144 -0.972 . . . . 1.0 109.274 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -65.48 -36.58 84.3 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 tp -63.62 -38.22 90.3 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.404 -0.961 . . . . 1.0 108.404 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.448 ' O ' ' OG1' ' A' ' 110' ' ' THR . 33.9 mtm180 -64.07 -36.2 83.23 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -65.73 -50.51 64.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 1.0 109.267 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.473 ' CG2' ' NZ ' ' A' ' 94' ' ' LYS . 22.9 t -65.95 -47.43 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.958 . . . . 1.0 110.349 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.594 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -65.98 -41.4 91.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.368 -0.833 . . . . 1.0 110.742 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 35.6 p -65.05 -45.75 84.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -0.99 . . . . 1.0 110.619 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -76.68 -28.64 56.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.799 -1.188 . . . . 1.0 109.836 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.33 -5.99 21.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 1.0 109.13 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.33 -5.76 49.31 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 110.103 -1.199 . . . . 1.0 110.103 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.492 ' O ' ' O ' ' A' ' 109' ' ' MET . 94.7 mt-10 -99.97 114.88 28.46 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.135 -1.215 . . . . 1.0 108.247 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -101.75 102.86 13.56 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.893 -1.13 . . . . 1.0 108.966 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.0 mt -104.36 148.13 26.74 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.698 0.761 . . . . 1.0 109.907 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.7 p -84.93 165.18 17.85 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.042 -1.096 . . . . 1.0 108.042 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -57.58 -31.94 66.67 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.868 -1.145 . . . . 1.0 109.678 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -74.84 -41.34 60.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.953 -1.092 . . . . 1.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -60.86 -38.01 84.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.088 -1.008 . . . . 1.0 108.76 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.55 -35.68 51.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.689 -1.226 . . . . 1.0 107.689 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.512 ' C ' ' HE ' ' A' ' 126' ' ' ARG . 46.8 t0 -57.78 -42.28 83.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.426 -1.324 . . . . 1.0 107.426 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.524 ' CA ' HH21 ' A' ' 126' ' ' ARG . 84.4 tt0 -61.7 -46.61 88.96 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.164 -0.96 . . . . 1.0 109.195 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 77.5 mtp -64.67 -42.63 95.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.102 -0.999 . . . . 1.0 109.682 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 129' ' ' ASP . 22.5 mm -65.37 -49.61 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.524 -0.735 . . . . 1.0 109.194 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.524 HH21 ' CA ' ' A' ' 123' ' ' GLU . 87.6 mtm180 -61.03 -38.17 85.15 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.317 -0.864 . . . . 1.0 109.877 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -72.28 -42.37 65.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.037 -1.039 . . . . 1.0 109.567 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.85 -22.82 31.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.099 -1.0 . . . . 1.0 110.175 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 125' ' ' ILE . 43.8 t0 -81.08 101.56 9.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.142 -0.974 . . . . 1.0 109.16 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 97.4 mt -86.06 -28.07 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.598 -0.689 . . . . 1.0 110.475 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 17.4 p30 -88.98 0.98 56.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.697 -1.252 . . . . 1.0 109.303 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.52 23.46 66.83 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 28.7 p-10 -76.99 -15.81 59.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.027 -1.278 . . . . 1.0 109.471 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.44 10.46 65.6 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -140.97 160.35 40.26 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.109 -1.23 . . . . 1.0 109.427 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.8 t -102.73 123.05 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.229 -0.919 . . . . 1.0 109.908 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.528 HD22 ' CD ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -95.61 173.99 7.21 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.246 -1.02 . . . . 1.0 108.246 178.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -55.39 -47.04 76.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.058 -1.027 . . . . 1.0 110.747 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.542 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 31.1 mp0 -60.05 -45.88 91.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.436 -1.415 . . . . 1.0 110.243 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.528 ' CD ' HD22 ' A' ' 137' ' ' ASN . 94.6 mt-10 -65.53 -39.28 91.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 1.0 109.769 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' SD ' ' A' ' 145' ' ' MET . 30.7 t80 -62.07 -44.3 96.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -0.934 . . . . 1.0 109.265 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 96.3 t -59.66 -50.56 79.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.107 -0.996 . . . . 1.0 109.281 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -61.86 -42.4 99.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.018 -1.051 . . . . 1.0 110.352 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.472 ' C ' ' SD ' ' A' ' 144' ' ' MET . 1.1 tmt? -64.36 -41.5 96.7 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.953 -1.092 . . . . 1.0 110.448 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 141' ' ' PHE . 2.0 mpt? . . . . . 0 N--CA 1.497 1.884 0 O-C-N 120.795 -1.19 . . . . 1.0 110.192 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.381 -0.599 . . . . 2.2799999999999998 109.381 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CG1' ' N ' ' A' ' 86' ' ' ARG . 6.4 pt -68.12 -43.51 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.967 . . . . 1.0700000000000001 109.801 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.421 ' N ' ' CG1' ' A' ' 85' ' ' ILE . 65.3 ttt180 -65.13 -46.32 81.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.037 . . . . 3.2799999999999998 109.737 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -57.24 -45.57 83.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.884 -1.135 . . . . 3.0499999999999998 108.388 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . 0.513 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.05 -41.38 92.19 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.011 -1.107 . . . . 1.1399999999999999 108.011 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.43 -39.93 94.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.121 -0.987 . . . . 0.14000000000000001 109.31 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.591 ' CG ' HH11 ' A' ' 90' ' ' ARG . 0.0 OUTLIER -71.64 -34.53 69.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 5.8399999999999999 108.793 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.5 t -65.19 -38.33 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 1.22 109.44 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 9.8 m-85 -78.11 -28.16 48.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -0.998 . . . . 0.26000000000000001 109.239 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 57.6 t0 -79.19 75.69 5.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.059 -1.026 . . . . 1.46 108.464 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -54.82 -38.21 67.08 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 116.055 -0.52 . . . . 4.7599999999999998 111.438 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.424 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 20.0 p30 -89.92 -2.97 58.28 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.837 -1.164 . . . . 3.1000000000000001 110.857 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.504 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . 65.58 24.01 70.8 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.984 -1.103 . . . . 0.67000000000000004 111.031 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.752 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -79.54 1.19 26.77 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.08 -1.247 . . . . 1.5700000000000001 110.387 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.59 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 78.46 -0.68 74.69 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.627 -1.296 . . . . 0.23999999999999999 110.911 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.752 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 22.7 m-85 -135.26 141.0 45.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.417 -1.049 . . . . 1.4099999999999999 109.941 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.5 mt -100.57 127.38 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.415 -0.803 . . . . 1.3300000000000001 109.363 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 p -87.46 160.0 18.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.738 . . . . 0.91000000000000003 109.322 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.2 93.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.32 -0.863 . . . . 1.02 109.671 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.08 74.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.158 -0.963 . . . . 1.02 108.952 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -66.46 -36.19 82.15 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.364 -1.347 . . . . 1.0600000000000001 107.364 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.0 tp -63.51 -34.44 77.79 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.607 -1.257 . . . . 1.21 107.607 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.513 ' NH1' ' OD1' ' A' ' 118' ' ' ASP . 61.3 ttt180 -67.6 -35.13 78.39 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.586 -0.697 . . . . 4.3499999999999996 109.284 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -67.74 -53.13 29.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.359 -0.838 . . . . 0.70999999999999996 109.652 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 109' ' ' MET . 5.2 m -66.68 -45.65 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.088 . . . . 0.97999999999999998 109.68 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 114' ' ' GLU . 14.5 mmt -65.3 -39.52 92.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 1.05 110.257 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 53.0 m -65.68 -43.39 89.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.889 . . . . 1.1100000000000001 110.525 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 113' ' ' GLY . 48.5 t-20 -79.72 -29.29 40.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.841 -1.162 . . . . 1.25 110.253 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.07 -1.74 1.06 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.95 -1.094 . . . . 1.5900000000000001 109.753 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 111' ' ' ASN . . . 99.61 -8.52 60.1 Favored Glycine 0 N--CA 1.499 2.884 0 N-CA-C 110.079 -1.208 . . . . 0.51000000000000001 110.079 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 109' ' ' MET . 94.2 mt-10 -94.88 120.03 34.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.089 -1.242 . . . . 2.29 108.119 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -105.8 100.05 9.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.126 -0.984 . . . . 2.2599999999999998 109.06 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.1 mt -105.84 149.9 26.09 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.656 0.741 . . . . 5.1399999999999997 109.857 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.589 ' HG1' ' H ' ' A' ' 120' ' ' GLU . 30.9 p -83.0 166.13 19.07 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.261 -1.014 . . . . 1.1599999999999999 108.261 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.513 ' OD1' ' NH1' ' A' ' 106' ' ' ARG . 81.6 m-20 -58.12 -36.45 72.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.943 -1.098 . . . . 1.6000000000000001 109.855 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -71.01 -39.89 72.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.826 -1.171 . . . . 1.75 109.15 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.589 ' H ' ' HG1' ' A' ' 117' ' ' THR . 97.7 mt-10 -64.7 -38.48 91.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.465 -0.939 . . . . 0.68000000000000005 108.465 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.1 t -70.48 -47.88 62.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.17 -1.048 . . . . 1.6399999999999999 108.17 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -52.22 -42.09 63.27 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.863 -1.162 . . . . 1.29 107.863 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -56.78 -43.66 81.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.119 -0.988 . . . . 3.1899999999999999 108.666 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.3 mmt -63.28 -42.12 99.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 2.7599999999999998 110.274 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 129' ' ' ASP . 2.7 mp -68.57 -44.06 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.044 -1.035 . . . . 1.04 109.247 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -61.87 -43.4 98.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -0.986 . . . . 5.3399999999999999 110.066 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -66.08 -39.24 89.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.011 -1.056 . . . . 1.95 109.418 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.34 -20.07 27.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.208 -0.932 . . . . 0.81000000000000005 110.458 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 125' ' ' ILE . 61.7 t0 -82.12 101.25 10.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.984 -1.073 . . . . 1.9299999999999999 109.293 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 130' ' ' ILE . 98.4 mt -90.2 -28.94 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.723 -0.611 . . . . 1.05 111.156 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -87.85 1.39 54.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.695 -1.253 . . . . 1.1499999999999999 109.797 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.33 76.69 0.22 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.786 -1.325 . . . . 1.1499999999999999 109.786 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 37.8 p-10 -133.64 -14.58 2.49 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -1.097 . . . . 2.4900000000000002 108.625 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 88.12 9.3 70.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.454 -1.058 . . . . 0.39000000000000001 110.454 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -141.45 161.43 37.91 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.149 -1.206 . . . . 2.5499999999999998 109.537 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.11 126.28 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.251 -0.906 . . . . 0.93999999999999995 110.209 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.523 HD22 ' CD ' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -97.21 177.52 5.54 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.551 -0.907 . . . . 3.0299999999999998 108.551 178.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.52 -47.04 87.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 1.95 111.081 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -58.22 -46.26 86.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.314 -1.491 . . . . 2.8999999999999999 109.877 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.523 ' CD ' HD22 ' A' ' 137' ' ' ASN . 95.8 mt-10 -66.25 -39.06 89.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 2.77 109.674 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 34.5 t80 -61.34 -43.65 98.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.245 -0.909 . . . . 0.46999999999999997 109.136 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.53 -50.59 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.393 -0.817 . . . . 1.25 109.61 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.24 -41.78 89.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.749 -1.22 . . . . 2.25 109.837 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 144' ' ' MET . 14.1 tmm? -67.38 -37.19 82.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 1.76 110.575 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.07 -1.019 . . . . 1.3300000000000001 110.919 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.99 -46.37 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.179 -0.951 . . . . 1.0 109.651 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -63.6 -45.69 89.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.028 . . . . 1.0 109.2 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -59.65 -46.57 88.63 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.904 -1.122 . . . . 1.0 108.789 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.61 95.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.992 . . . . 1.0 108.494 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.55 -40.68 97.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.111 -0.993 . . . . 1.0 109.305 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -71.39 -34.09 70.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.995 -1.066 . . . . 1.0 109.214 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.511 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . 62.2 t -67.74 -33.62 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.029 . . . . 1.0 109.484 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 4.4 m-30 -80.74 -28.2 36.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.904 -1.122 . . . . 1.0 108.743 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.507 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 2.5 t70 -76.73 74.59 3.39 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 91' ' ' VAL . 52.4 mmtt -55.04 -40.18 69.97 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.389 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -89.98 -1.55 57.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.919 -1.113 . . . . 1.0 110.519 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.38 22.02 70.87 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.885 -1.15 . . . . 1.0 110.306 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.507 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 48.3 p-10 -75.67 -3.81 36.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -1.092 . . . . 1.0 110.249 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.41 7.85 88.19 Favored Glycine 0 N--CA 1.49 2.261 0 O-C-N 120.665 -1.272 . . . . 1.0 111.006 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 45.9 m-85 -141.36 135.65 30.69 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.097 -1.237 . . . . 1.0 109.623 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.8 mt -93.31 125.78 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.222 -0.924 . . . . 1.0 109.399 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.0 t -90.26 158.8 17.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.76 . . . . 1.0 109.377 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.87 -43.67 81.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.371 -0.831 . . . . 1.0 109.612 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.22 -32.65 74.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.965 . . . . 1.0 109.254 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -67.37 -38.56 84.94 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.78 -34.36 77.74 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.913 -1.143 . . . . 1.0 107.913 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.442 ' O ' ' OG1' ' A' ' 110' ' ' THR . 42.0 ttp180 -66.97 -34.54 77.99 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.523 -0.735 . . . . 1.0 109.068 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -68.14 -53.64 23.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.317 -0.865 . . . . 1.0 109.811 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 109' ' ' MET . 3.1 m -65.61 -46.27 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.92 -1.113 . . . . 1.0 110.003 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.484 ' O ' ' O ' ' A' ' 114' ' ' GLU . 14.2 mmt -65.69 -39.73 91.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 1.0 110.554 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 54.9 m -64.72 -45.47 86.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 1.0 110.752 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -76.39 -26.45 55.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.719 -1.238 . . . . 1.0 110.108 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.0 mt -68.52 -2.74 9.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 1.0 109.726 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.71 -5.77 56.91 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.118 -1.193 . . . . 1.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 109' ' ' MET . 70.1 mm-40 -102.05 115.44 30.55 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.231 -1.158 . . . . 1.0 108.044 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -101.54 105.51 16.49 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.87 -1.144 . . . . 1.0 109.16 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 10.0 mp -102.73 145.23 30.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 1.0 109.403 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.6 p -81.07 166.21 20.94 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -57.49 -34.31 68.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.864 -1.147 . . . . 1.0 109.475 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 42.0 mp0 -74.39 -39.48 62.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.938 -1.101 . . . . 1.0 109.178 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.71 -38.66 91.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.95 . . . . 1.0 108.678 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.9 t -71.71 -36.51 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 107.566 -1.272 . . . . 1.0 107.566 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.3 -44.86 92.48 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.538 -1.282 . . . . 1.0 107.538 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.427 ' O ' ' OE2' ' A' ' 127' ' ' GLU . 85.8 tt0 -56.85 -46.75 81.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 1.0 108.959 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.0 mtt -65.02 -41.42 95.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 1.0 109.744 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 129' ' ' ASP . 5.8 mm -66.1 -48.5 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.812 . . . . 1.0 109.843 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -62.09 -39.73 93.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 1.0 109.939 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -69.39 -40.25 77.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.001 -1.062 . . . . 1.0 109.27 -179.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.24 -21.76 28.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.07 -1.019 . . . . 1.0 110.257 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 125' ' ' ILE . 33.2 t0 -82.72 103.54 12.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.118 -0.989 . . . . 1.0 109.158 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.427 HD12 HG21 ' A' ' 130' ' ' ILE . 98.5 mt -87.99 -28.63 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.502 -0.749 . . . . 1.0 111.024 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 47.5 p30 -87.68 2.79 50.1 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.546 -1.346 . . . . 1.0 109.573 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.64 18.26 51.52 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.163 -1.175 . . . . 1.0 110.163 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 23.2 p-10 -71.57 -11.49 60.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.938 -1.331 . . . . 1.0 109.162 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.44 77.4 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.281 -1.128 . . . . 1.0 110.281 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -140.11 163.55 32.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.24 -1.153 . . . . 1.0 109.222 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.02 124.18 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.297 -0.877 . . . . 1.0 109.667 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -95.24 179.25 5.25 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -59.95 -45.7 91.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 1.0 110.885 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -58.87 -46.28 88.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.469 -1.394 . . . . 1.0 109.949 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.55 -36.46 82.73 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.4 -0.812 . . . . 1.0 109.313 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.03 -43.53 98.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.408 -0.807 . . . . 1.0 109.089 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.06 -51.0 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.102 -0.999 . . . . 1.0 109.443 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -59.28 -42.75 91.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.859 -1.15 . . . . 1.0 110.02 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . 0.547 ' SD ' ' SD ' ' A' ' 145' ' ' MET . 1.0 OUTLIER -65.58 -35.35 80.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 1.0 110.482 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.547 ' SD ' ' SD ' ' A' ' 144' ' ' MET . 71.7 mmm . . . . . 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 1.0 110.405 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.01 -39.79 93.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.637 -1.289 . . . . 1.0 109.05 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -61.61 -43.52 98.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 1.0 108.587 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.27 -43.47 81.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.303 -0.873 . . . . 1.0 109.524 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.56 ' CG ' HH11 ' A' ' 86' ' ' ARG . 0.4 OUTLIER -65.08 -50.39 66.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 1.0 109.362 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -58.26 -44.96 88.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.878 -1.139 . . . . 1.0 108.412 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.61 97.62 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -62.9 -40.22 96.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.027 -1.045 . . . . 1.0 109.279 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.585 HH21 ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -69.72 -32.74 71.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.937 -1.102 . . . . 1.0 108.996 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.46 -36.69 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.949 . . . . 1.0 109.879 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -79.76 -25.93 40.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.966 -1.084 . . . . 1.0 109.606 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 98' ' ' GLY . 53.8 t0 -79.74 74.26 6.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 1.0 108.556 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' NZ ' ' CG2' ' A' ' 108' ' ' VAL . 12.1 mptt -54.14 -38.74 65.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.873 -0.517 . . . . 1.0 110.798 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 9.4 p30 -88.31 -4.9 58.61 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.121 -0.987 . . . . 1.0 110.952 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.585 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . 67.63 23.1 73.78 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.599 -1.286 . . . . 1.0 110.187 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.486 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 50.5 p-10 -76.69 -3.06 36.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -1.14 . . . . 1.0 110.73 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.433 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 79.34 5.17 89.24 Favored Glycine 0 N--CA 1.489 2.193 0 O-C-N 120.591 -1.318 . . . . 1.0 110.538 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 31.3 m-85 -139.44 138.84 36.8 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.303 -1.116 . . . . 1.0 109.822 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.0 mt -96.31 122.24 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 1.0 109.06 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 t -84.78 158.97 20.55 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.509 0.671 . . . . 1.0 109.575 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.71 90.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.342 -0.849 . . . . 1.0 109.698 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.53 -33.65 76.06 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.144 -0.972 . . . . 1.0 109.274 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -65.48 -36.58 84.3 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 tp -63.62 -38.22 90.3 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.404 -0.961 . . . . 1.0 108.404 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.448 ' O ' ' OG1' ' A' ' 110' ' ' THR . 33.9 mtm180 -64.07 -36.2 83.23 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -65.73 -50.51 64.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 1.0 109.267 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.473 ' CG2' ' NZ ' ' A' ' 94' ' ' LYS . 22.9 t -65.95 -47.43 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.958 . . . . 1.0 110.349 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.594 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -65.98 -41.4 91.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.368 -0.833 . . . . 1.0 110.742 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 35.6 p -65.05 -45.75 84.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -0.99 . . . . 1.0 110.619 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -76.68 -28.64 56.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.799 -1.188 . . . . 1.0 109.836 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.33 -5.99 21.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 1.0 109.13 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.33 -5.76 49.31 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 110.103 -1.199 . . . . 1.0 110.103 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.492 ' O ' ' O ' ' A' ' 109' ' ' MET . 94.7 mt-10 -99.97 114.88 28.46 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.135 -1.215 . . . . 1.0 108.247 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -101.75 102.86 13.56 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.893 -1.13 . . . . 1.0 108.966 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.0 mt -104.36 148.13 26.74 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.698 0.761 . . . . 1.0 109.907 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.7 p -84.93 165.18 17.85 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.042 -1.096 . . . . 1.0 108.042 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -57.58 -31.94 66.67 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.868 -1.145 . . . . 1.0 109.678 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -74.84 -41.34 60.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.953 -1.092 . . . . 1.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -60.86 -38.01 84.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.088 -1.008 . . . . 1.0 108.76 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.55 -35.68 51.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.689 -1.226 . . . . 1.0 107.689 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.512 ' C ' ' HE ' ' A' ' 126' ' ' ARG . 46.8 t0 -57.78 -42.28 83.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.426 -1.324 . . . . 1.0 107.426 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.524 ' CA ' HH21 ' A' ' 126' ' ' ARG . 84.4 tt0 -61.7 -46.61 88.96 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.164 -0.96 . . . . 1.0 109.195 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 77.5 mtp -64.67 -42.63 95.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.102 -0.999 . . . . 1.0 109.682 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 129' ' ' ASP . 22.5 mm -65.37 -49.61 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.524 -0.735 . . . . 1.0 109.194 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.524 HH21 ' CA ' ' A' ' 123' ' ' GLU . 87.6 mtm180 -61.03 -38.17 85.15 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.317 -0.864 . . . . 1.0 109.877 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -72.28 -42.37 65.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.037 -1.039 . . . . 1.0 109.567 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.85 -22.82 31.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.099 -1.0 . . . . 1.0 110.175 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 125' ' ' ILE . 43.8 t0 -81.08 101.56 9.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.142 -0.974 . . . . 1.0 109.16 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 97.4 mt -86.06 -28.07 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.598 -0.689 . . . . 1.0 110.475 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 17.4 p30 -88.98 0.98 56.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.697 -1.252 . . . . 1.0 109.303 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.52 23.46 66.83 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 28.7 p-10 -76.99 -15.81 59.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.027 -1.278 . . . . 1.0 109.471 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.44 10.46 65.6 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -140.97 160.35 40.26 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.109 -1.23 . . . . 1.0 109.427 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.8 t -102.73 123.05 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.229 -0.919 . . . . 1.0 109.908 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.528 HD22 ' CD ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -95.61 173.99 7.21 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.246 -1.02 . . . . 1.0 108.246 178.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -55.39 -47.04 76.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.058 -1.027 . . . . 1.0 110.747 -179.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.542 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 31.1 mp0 -60.05 -45.88 91.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.436 -1.415 . . . . 1.0 110.243 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.528 ' CD ' HD22 ' A' ' 137' ' ' ASN . 94.6 mt-10 -65.53 -39.28 91.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 1.0 109.769 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' SD ' ' A' ' 145' ' ' MET . 30.7 t80 -62.07 -44.3 96.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -0.934 . . . . 1.0 109.265 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 146' ' ' THR . 96.3 t -59.66 -50.56 79.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.107 -0.996 . . . . 1.0 109.281 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -61.86 -42.4 99.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.018 -1.051 . . . . 1.0 110.352 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.472 ' C ' ' SD ' ' A' ' 144' ' ' MET . 1.1 tmt? -64.36 -41.5 96.7 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.953 -1.092 . . . . 1.0 110.448 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 141' ' ' PHE . 2.0 mpt? -91.01 -22.64 20.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.795 -1.19 . . . . 1.0 110.192 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 142' ' ' VAL . 2.5 m -109.9 24.14 13.43 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 108.439 -0.948 . . . . 1.0 108.439 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.69 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.029 -1.045 . . . . 1.0 109.301 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 146' ' ' THR . 4.9 tmtt? . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 1.0 109.166 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1000 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1001 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.712 0.768 . . . . 2.79 109.477 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -71.54 -36.01 70.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.667 -0.646 . . . . 2.2200000000000002 110.096 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -62.83 -54.25 41.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.883 -1.136 . . . . 2.2799999999999998 109.381 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CG1' ' N ' ' A' ' 86' ' ' ARG . 6.4 pt -68.12 -43.51 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.967 . . . . 1.0700000000000001 109.801 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.421 ' N ' ' CG1' ' A' ' 85' ' ' ILE . 65.3 ttt180 -65.13 -46.32 81.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.037 . . . . 3.2799999999999998 109.737 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -57.24 -45.57 83.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.884 -1.135 . . . . 3.0499999999999998 108.388 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.513 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.05 -41.38 92.19 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.011 -1.107 . . . . 1.1399999999999999 108.011 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.43 -39.93 94.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.121 -0.987 . . . . 0.14000000000000001 109.31 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.591 ' CG ' HH11 ' A' ' 90' ' ' ARG . 0.0 OUTLIER -71.64 -34.53 69.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 5.8399999999999999 108.793 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.5 t -65.19 -38.33 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 1.22 109.44 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 9.8 m-85 -78.11 -28.16 48.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -0.998 . . . . 0.26000000000000001 109.239 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 57.6 t0 -79.19 75.69 5.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.059 -1.026 . . . . 1.46 108.464 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -54.82 -38.21 67.08 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 116.055 -0.52 . . . . 4.7599999999999998 111.438 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.424 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 20.0 p30 -89.92 -2.97 58.28 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.837 -1.164 . . . . 3.1000000000000001 110.857 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.504 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . 65.58 24.01 70.8 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.984 -1.103 . . . . 0.67000000000000004 111.031 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.752 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -79.54 1.19 26.77 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.08 -1.247 . . . . 1.5700000000000001 110.387 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.59 ' N ' HD21 ' A' ' 97' ' ' ASN . . . 78.46 -0.68 74.69 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.627 -1.296 . . . . 0.23999999999999999 110.911 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.752 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 22.7 m-85 -135.26 141.0 45.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.417 -1.049 . . . . 1.4099999999999999 109.941 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.5 mt -100.57 127.38 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.415 -0.803 . . . . 1.3300000000000001 109.363 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 p -87.46 160.0 18.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.738 . . . . 0.91000000000000003 109.322 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.2 93.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.32 -0.863 . . . . 1.02 109.671 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.08 74.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.158 -0.963 . . . . 1.02 108.952 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -66.46 -36.19 82.15 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.364 -1.347 . . . . 1.0600000000000001 107.364 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.0 tp -63.51 -34.44 77.79 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.607 -1.257 . . . . 1.21 107.607 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.513 ' NH1' ' OD1' ' A' ' 118' ' ' ASP . 61.3 ttt180 -67.6 -35.13 78.39 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.586 -0.697 . . . . 4.3499999999999996 109.284 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -67.74 -53.13 29.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.359 -0.838 . . . . 0.70999999999999996 109.652 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.449 ' CG2' ' N ' ' A' ' 109' ' ' MET . 5.2 m -66.68 -45.65 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.088 . . . . 0.97999999999999998 109.68 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 114' ' ' GLU . 14.5 mmt -65.3 -39.52 92.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 1.05 110.257 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 53.0 m -65.68 -43.39 89.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.889 . . . . 1.1100000000000001 110.525 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.424 ' C ' ' H ' ' A' ' 113' ' ' GLY . 48.5 t-20 -79.72 -29.29 40.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.841 -1.162 . . . . 1.25 110.253 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.07 -1.74 1.06 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.95 -1.094 . . . . 1.5900000000000001 109.753 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 111' ' ' ASN . . . 99.61 -8.52 60.1 Favored Glycine 0 N--CA 1.499 2.884 0 N-CA-C 110.079 -1.208 . . . . 0.51000000000000001 110.079 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 109' ' ' MET . 94.2 mt-10 -94.88 120.03 34.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.089 -1.242 . . . . 2.29 108.119 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -105.8 100.05 9.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.126 -0.984 . . . . 2.2599999999999998 109.06 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.1 mt -105.84 149.9 26.09 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.656 0.741 . . . . 5.1399999999999997 109.857 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.589 ' HG1' ' H ' ' A' ' 120' ' ' GLU . 30.9 p -83.0 166.13 19.07 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.261 -1.014 . . . . 1.1599999999999999 108.261 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.513 ' OD1' ' NH1' ' A' ' 106' ' ' ARG . 81.6 m-20 -58.12 -36.45 72.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.943 -1.098 . . . . 1.6000000000000001 109.855 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -71.01 -39.89 72.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.826 -1.171 . . . . 1.75 109.15 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.589 ' H ' ' HG1' ' A' ' 117' ' ' THR . 97.7 mt-10 -64.7 -38.48 91.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.465 -0.939 . . . . 0.68000000000000005 108.465 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.1 t -70.48 -47.88 62.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.17 -1.048 . . . . 1.6399999999999999 108.17 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -52.22 -42.09 63.27 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.863 -1.162 . . . . 1.29 107.863 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -56.78 -43.66 81.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.119 -0.988 . . . . 3.1899999999999999 108.666 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.3 mmt -63.28 -42.12 99.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 2.7599999999999998 110.274 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 129' ' ' ASP . 2.7 mp -68.57 -44.06 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.044 -1.035 . . . . 1.04 109.247 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -61.87 -43.4 98.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -0.986 . . . . 5.3399999999999999 110.066 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -66.08 -39.24 89.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.011 -1.056 . . . . 1.95 109.418 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.34 -20.07 27.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.208 -0.932 . . . . 0.81000000000000005 110.458 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 125' ' ' ILE . 61.7 t0 -82.12 101.25 10.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.984 -1.073 . . . . 1.9299999999999999 109.293 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 130' ' ' ILE . 98.4 mt -90.2 -28.94 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.723 -0.611 . . . . 1.05 111.156 -178.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -87.85 1.39 54.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.695 -1.253 . . . . 1.1499999999999999 109.797 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.33 76.69 0.22 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.786 -1.325 . . . . 1.1499999999999999 109.786 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 37.8 p-10 -133.64 -14.58 2.49 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -1.097 . . . . 2.4900000000000002 108.625 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 88.12 9.3 70.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.454 -1.058 . . . . 0.39000000000000001 110.454 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -141.45 161.43 37.91 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.149 -1.206 . . . . 2.5499999999999998 109.537 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.11 126.28 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.251 -0.906 . . . . 0.93999999999999995 110.209 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.523 HD22 ' CD ' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -97.21 177.52 5.54 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.551 -0.907 . . . . 3.0299999999999998 108.551 178.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.52 -47.04 87.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 1.95 111.081 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -58.22 -46.26 86.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.314 -1.491 . . . . 2.8999999999999999 109.877 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.523 ' CD ' HD22 ' A' ' 137' ' ' ASN . 95.8 mt-10 -66.25 -39.06 89.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 2.77 109.674 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 34.5 t80 -61.34 -43.65 98.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.245 -0.909 . . . . 0.46999999999999997 109.136 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 146' ' ' THR . 95.0 t -61.53 -50.59 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.393 -0.817 . . . . 1.25 109.61 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.24 -41.78 89.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.749 -1.22 . . . . 2.25 109.837 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 144' ' ' MET . 14.1 tmm? -67.38 -37.19 82.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 1.76 110.575 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -93.17 -28.49 16.26 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.07 -1.019 . . . . 1.3300000000000001 110.919 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 142' ' ' VAL . 38.6 m -52.56 -48.64 66.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 1.21 109.249 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 46.86 -140.64 0.49 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 2.0800000000000001 109.747 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 3.04 109.463 -179.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1000 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 1001 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.603 -0.517 . . . . 1.0 109.603 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -63.51 -36.91 85.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.931 -1.106 . . . . 1.0 108.213 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.99 -38.85 89.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.399 -0.813 . . . . 1.0 109.284 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.99 -46.37 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.179 -0.951 . . . . 1.0 109.651 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -63.6 -45.69 89.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.028 . . . . 1.0 109.2 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -59.65 -46.57 88.63 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.904 -1.122 . . . . 1.0 108.789 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.61 95.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.992 . . . . 1.0 108.494 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.55 -40.68 97.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.111 -0.993 . . . . 1.0 109.305 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -71.39 -34.09 70.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.995 -1.066 . . . . 1.0 109.214 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.511 ' O ' ' NZ ' ' A' ' 94' ' ' LYS . 62.2 t -67.74 -33.62 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.029 . . . . 1.0 109.484 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 4.4 m-30 -80.74 -28.2 36.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.904 -1.122 . . . . 1.0 108.743 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.507 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 2.5 t70 -76.73 74.59 3.39 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.511 ' NZ ' ' O ' ' A' ' 91' ' ' VAL . 52.4 mmtt -55.04 -40.18 69.97 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.389 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -89.98 -1.55 57.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.919 -1.113 . . . . 1.0 110.519 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.38 22.02 70.87 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.885 -1.15 . . . . 1.0 110.306 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.507 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 48.3 p-10 -75.67 -3.81 36.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -1.092 . . . . 1.0 110.249 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.41 7.85 88.19 Favored Glycine 0 N--CA 1.49 2.261 0 O-C-N 120.665 -1.272 . . . . 1.0 111.006 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 45.9 m-85 -141.36 135.65 30.69 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.097 -1.237 . . . . 1.0 109.623 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.8 mt -93.31 125.78 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.222 -0.924 . . . . 1.0 109.399 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.0 t -90.26 158.8 17.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.76 . . . . 1.0 109.377 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -56.87 -43.67 81.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.371 -0.831 . . . . 1.0 109.612 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.22 -32.65 74.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.965 . . . . 1.0 109.254 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -67.37 -38.56 84.94 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.78 -34.36 77.74 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.913 -1.143 . . . . 1.0 107.913 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.442 ' O ' ' OG1' ' A' ' 110' ' ' THR . 42.0 ttp180 -66.97 -34.54 77.99 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.523 -0.735 . . . . 1.0 109.068 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -68.14 -53.64 23.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.317 -0.865 . . . . 1.0 109.811 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.474 ' CG2' ' N ' ' A' ' 109' ' ' MET . 3.1 m -65.61 -46.27 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.92 -1.113 . . . . 1.0 110.003 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.484 ' O ' ' O ' ' A' ' 114' ' ' GLU . 14.2 mmt -65.69 -39.73 91.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 1.0 110.554 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.442 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 54.9 m -64.72 -45.47 86.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 1.0 110.752 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -76.39 -26.45 55.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.719 -1.238 . . . . 1.0 110.108 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.0 mt -68.52 -2.74 9.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 1.0 109.726 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.71 -5.77 56.91 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.118 -1.193 . . . . 1.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 109' ' ' MET . 70.1 mm-40 -102.05 115.44 30.55 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.231 -1.158 . . . . 1.0 108.044 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -101.54 105.51 16.49 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.87 -1.144 . . . . 1.0 109.16 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.4 ' CD1' ' N ' ' A' ' 116' ' ' LEU . 10.0 mp -102.73 145.23 30.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 1.0 109.403 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.6 p -81.07 166.21 20.94 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -57.49 -34.31 68.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.864 -1.147 . . . . 1.0 109.475 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.491 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 42.0 mp0 -74.39 -39.48 62.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.938 -1.101 . . . . 1.0 109.178 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.71 -38.66 91.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.95 . . . . 1.0 108.678 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.9 t -71.71 -36.51 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 107.566 -1.272 . . . . 1.0 107.566 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.3 -44.86 92.48 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.538 -1.282 . . . . 1.0 107.538 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.427 ' O ' ' OE2' ' A' ' 127' ' ' GLU . 85.8 tt0 -56.85 -46.75 81.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 1.0 108.959 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.0 mtt -65.02 -41.42 95.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 1.0 109.744 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 129' ' ' ASP . 5.8 mm -66.1 -48.5 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.812 . . . . 1.0 109.843 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -62.09 -39.73 93.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 1.0 109.939 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -69.39 -40.25 77.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.001 -1.062 . . . . 1.0 109.27 -179.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.24 -21.76 28.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.07 -1.019 . . . . 1.0 110.257 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 125' ' ' ILE . 33.2 t0 -82.72 103.54 12.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.118 -0.989 . . . . 1.0 109.158 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.427 HD12 HG21 ' A' ' 130' ' ' ILE . 98.5 mt -87.99 -28.63 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.502 -0.749 . . . . 1.0 111.024 -178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 47.5 p30 -87.68 2.79 50.1 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.546 -1.346 . . . . 1.0 109.573 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.64 18.26 51.52 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.163 -1.175 . . . . 1.0 110.163 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 23.2 p-10 -71.57 -11.49 60.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.938 -1.331 . . . . 1.0 109.162 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.44 77.4 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.281 -1.128 . . . . 1.0 110.281 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -140.11 163.55 32.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.24 -1.153 . . . . 1.0 109.222 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.02 124.18 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.297 -0.877 . . . . 1.0 109.667 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -95.24 179.25 5.25 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -59.95 -45.7 91.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 1.0 110.885 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -58.87 -46.28 88.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.469 -1.394 . . . . 1.0 109.949 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.55 -36.46 82.73 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.4 -0.812 . . . . 1.0 109.313 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.03 -43.53 98.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.408 -0.807 . . . . 1.0 109.089 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 146' ' ' THR . 98.0 t -62.06 -51.0 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.102 -0.999 . . . . 1.0 109.443 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -59.28 -42.75 91.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.859 -1.15 . . . . 1.0 110.02 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . 0.547 ' SD ' ' SD ' ' A' ' 145' ' ' MET . 1.0 OUTLIER -65.58 -35.35 80.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 1.0 110.482 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.547 ' SD ' ' SD ' ' A' ' 144' ' ' MET . 71.7 mmm -93.03 -25.16 18.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 1.0 110.405 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.501 ' N ' ' O ' ' A' ' 142' ' ' VAL . 27.1 p -113.74 25.54 11.13 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.13 140.27 21.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.063 -1.023 . . . . 1.0 109.244 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.7 mttp . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 1.0 109.482 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1000 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 1001 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.42 HG21 HG22 ' A' ' 142' ' ' VAL . 69.8 mt -69.27 -43.47 81.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.303 -0.873 . . . . 1.0 109.524 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' A' ' 86' ' ' ARG . 0.4 OUTLIER -65.08 -50.39 66.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 1.0 109.362 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -58.26 -44.96 88.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.878 -1.139 . . . . 1.0 108.412 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.61 97.62 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -62.9 -40.22 96.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.027 -1.045 . . . . 1.0 109.279 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.605 HH21 ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -69.72 -32.74 71.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.937 -1.102 . . . . 1.0 108.996 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.46 -36.69 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.949 . . . . 1.0 109.879 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 108' ' ' VAL . 3.2 m-85 -79.76 -25.93 40.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.966 -1.084 . . . . 1.0 109.606 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 98' ' ' GLY . 53.8 t0 -79.74 74.26 6.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 1.0 108.556 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.489 ' HZ1' HG22 ' A' ' 108' ' ' VAL . 12.1 mptt -54.14 -38.74 65.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.873 -0.517 . . . . 1.0 110.798 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 9.4 p30 -88.31 -4.9 58.61 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.121 -0.987 . . . . 1.0 110.952 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.605 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . 67.63 23.1 73.78 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.599 -1.286 . . . . 1.0 110.187 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.486 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 50.5 p-10 -76.69 -3.06 36.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -1.14 . . . . 1.0 110.73 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.433 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 79.34 5.17 89.24 Favored Glycine 0 N--CA 1.489 2.193 0 O-C-N 120.591 -1.318 . . . . 1.0 110.538 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 31.3 m-85 -139.44 138.84 36.8 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.303 -1.116 . . . . 1.0 109.822 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.0 mt -96.31 122.24 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 1.0 109.06 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 t -84.78 158.97 20.55 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.509 0.671 . . . . 1.0 109.575 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.71 90.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.342 -0.849 . . . . 1.0 109.698 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.429 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -63.53 -33.65 76.06 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.144 -0.972 . . . . 1.0 109.274 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -65.48 -36.58 84.3 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 tp -63.62 -38.22 90.3 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.404 -0.961 . . . . 1.0 108.404 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.568 ' O ' HG23 ' A' ' 110' ' ' THR . 33.9 mtm180 -64.07 -36.2 83.23 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -65.73 -50.51 64.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 1.0 109.267 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.489 HG22 ' HZ1' ' A' ' 94' ' ' LYS . 22.9 t -65.95 -47.43 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.958 . . . . 1.0 110.349 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.594 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -65.98 -41.4 91.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.368 -0.833 . . . . 1.0 110.742 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 106' ' ' ARG . 35.6 p -65.05 -45.75 84.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -0.99 . . . . 1.0 110.619 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -76.68 -28.64 56.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.799 -1.188 . . . . 1.0 109.836 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.33 -5.99 21.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 1.0 109.13 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.33 -5.76 49.31 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 110.103 -1.199 . . . . 1.0 110.103 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.492 ' O ' ' O ' ' A' ' 109' ' ' MET . 94.7 mt-10 -99.97 114.88 28.46 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.135 -1.215 . . . . 1.0 108.247 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -101.75 102.86 13.56 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.893 -1.13 . . . . 1.0 108.966 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.0 mt -104.36 148.13 26.74 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.698 0.761 . . . . 1.0 109.907 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.7 p -84.93 165.18 17.85 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.042 -1.096 . . . . 1.0 108.042 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -57.58 -31.94 66.67 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.868 -1.145 . . . . 1.0 109.678 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -74.84 -41.34 60.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.953 -1.092 . . . . 1.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -60.86 -38.01 84.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.088 -1.008 . . . . 1.0 108.76 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.55 -35.68 51.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.689 -1.226 . . . . 1.0 107.689 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.546 ' C ' ' HE ' ' A' ' 126' ' ' ARG . 46.8 t0 -57.78 -42.28 83.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.426 -1.324 . . . . 1.0 107.426 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.538 ' CA ' HH21 ' A' ' 126' ' ' ARG . 84.4 tt0 -61.7 -46.61 88.96 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.164 -0.96 . . . . 1.0 109.195 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 77.5 mtp -64.67 -42.63 95.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.102 -0.999 . . . . 1.0 109.682 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 129' ' ' ASP . 22.5 mm -65.37 -49.61 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.524 -0.735 . . . . 1.0 109.194 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.546 ' HE ' ' C ' ' A' ' 122' ' ' ASP . 87.6 mtm180 -61.03 -38.17 85.15 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.317 -0.864 . . . . 1.0 109.877 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -72.28 -42.37 65.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.037 -1.039 . . . . 1.0 109.567 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.85 -22.82 31.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.099 -1.0 . . . . 1.0 110.175 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 125' ' ' ILE . 43.8 t0 -81.08 101.56 9.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.142 -0.974 . . . . 1.0 109.16 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 97.4 mt -86.06 -28.07 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.598 -0.689 . . . . 1.0 110.475 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 17.4 p30 -88.98 0.98 56.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.697 -1.252 . . . . 1.0 109.303 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.52 23.46 66.83 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 28.7 p-10 -76.99 -15.81 59.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.027 -1.278 . . . . 1.0 109.471 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.44 10.46 65.6 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -140.97 160.35 40.26 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.109 -1.23 . . . . 1.0 109.427 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.8 t -102.73 123.05 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.229 -0.919 . . . . 1.0 109.908 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.551 HD21 ' CD ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -95.61 173.99 7.21 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.246 -1.02 . . . . 1.0 108.246 178.626 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 142' ' ' VAL . 86.1 t80 -55.39 -47.04 76.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.058 -1.027 . . . . 1.0 110.747 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.623 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 31.1 mp0 -60.05 -45.88 91.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.436 -1.415 . . . . 1.0 110.243 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.551 ' CD ' HD21 ' A' ' 137' ' ' ASN . 94.6 mt-10 -65.53 -39.28 91.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 1.0 109.769 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' SD ' ' A' ' 145' ' ' MET . 30.7 t80 -62.07 -44.3 96.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -0.934 . . . . 1.0 109.265 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 138' ' ' TYR . 96.3 t -59.66 -50.56 79.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.107 -0.996 . . . . 1.0 109.281 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -61.86 -42.4 99.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.018 -1.051 . . . . 1.0 110.352 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.472 ' C ' ' SD ' ' A' ' 144' ' ' MET . 1.1 tmt? -64.36 -41.5 96.7 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.953 -1.092 . . . . 1.0 110.448 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 141' ' ' PHE . 2.0 mpt? . . . . . 0 N--CA 1.497 1.884 0 O-C-N 120.795 -1.19 . . . . 1.0 110.192 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.381 -0.599 . . . . 2.2799999999999998 109.381 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CG1' ' N ' ' A' ' 86' ' ' ARG . 6.4 pt -68.12 -43.51 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.967 . . . . 0.29999999999999999 109.801 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.421 ' N ' ' CG1' ' A' ' 85' ' ' ILE . 65.3 ttt180 -65.13 -46.32 81.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.037 . . . . 2.7200000000000002 109.737 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -57.24 -45.57 83.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.884 -1.135 . . . . 3.0499999999999998 108.388 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.513 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.05 -41.38 92.19 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.011 -1.107 . . . . 0.070000000000000007 108.011 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.43 -39.93 94.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.121 -0.987 . . . . 0.11 109.31 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.604 HH11 ' CG ' ' A' ' 90' ' ' ARG . 0.0 OUTLIER -71.64 -34.53 69.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 4.6900000000000004 108.793 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.5 t -65.19 -38.33 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.11 109.44 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 9.8 m-85 -78.11 -28.16 48.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -0.998 . . . . 0.20999999999999999 109.239 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.467 ' OD2' ' N ' ' A' ' 98' ' ' GLY . 57.6 t0 -79.19 75.69 5.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.059 -1.026 . . . . 1.46 108.464 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -54.82 -38.21 67.08 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 116.055 -0.52 . . . . 3.98 111.438 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.424 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 20.0 p30 -89.92 -2.97 58.28 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.837 -1.164 . . . . 3.1000000000000001 110.857 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.525 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . 65.58 24.01 70.8 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.984 -1.103 . . . . 0.46000000000000002 111.031 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.2 p30 -79.54 1.19 26.77 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.08 -1.247 . . . . 1.3100000000000001 110.387 -179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.467 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 78.46 -0.68 74.69 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.627 -1.296 . . . . 0.23000000000000001 110.911 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -135.26 141.0 45.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.417 -1.049 . . . . 0.81000000000000005 109.941 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.5 mt -100.57 127.38 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.415 -0.803 . . . . 0.31 109.363 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 p -87.46 160.0 18.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.738 . . . . 0.20999999999999999 109.322 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.2 93.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.32 -0.863 . . . . 0.11 109.671 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.08 74.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.158 -0.963 . . . . 0.12 108.952 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -66.46 -36.19 82.15 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.364 -1.347 . . . . 0.81000000000000005 107.364 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.0 tp -63.51 -34.44 77.79 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.607 -1.257 . . . . 0.16 107.607 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.513 ' NH1' ' OD1' ' A' ' 118' ' ' ASP . 61.3 ttt180 -67.6 -35.13 78.39 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.586 -0.697 . . . . 3.52 109.284 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -67.74 -53.13 29.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.359 -0.838 . . . . 0.48999999999999999 109.652 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 109' ' ' MET . 5.2 m -66.68 -45.65 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.088 . . . . 0.10000000000000001 109.68 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.518 ' N ' HG23 ' A' ' 108' ' ' VAL . 14.5 mmt -65.3 -39.52 92.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.12 110.257 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 53.0 m -65.68 -43.39 89.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.889 . . . . 0.17999999999999999 110.525 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -79.72 -29.29 40.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.841 -1.162 . . . . 1.1200000000000001 110.253 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.07 -1.74 1.06 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.95 -1.094 . . . . 0.45000000000000001 109.753 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.61 -8.52 60.1 Favored Glycine 0 N--CA 1.499 2.884 0 N-CA-C 110.079 -1.208 . . . . 0.40999999999999998 110.079 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 109' ' ' MET . 94.2 mt-10 -94.88 120.03 34.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.089 -1.242 . . . . 2.29 108.119 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -105.8 100.05 9.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.126 -0.984 . . . . 1.51 109.06 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.1 mt -105.84 149.9 26.09 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.656 0.741 . . . . 3.77 109.857 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.9 p -83.0 166.13 19.07 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.261 -1.014 . . . . 0.29999999999999999 108.261 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.513 ' OD1' ' NH1' ' A' ' 106' ' ' ARG . 81.6 m-20 -58.12 -36.45 72.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.943 -1.098 . . . . 1.6000000000000001 109.855 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -71.01 -39.89 72.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.826 -1.171 . . . . 1.75 109.15 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.7 -38.48 91.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.465 -0.939 . . . . 0.68000000000000005 108.465 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.1 t -70.48 -47.88 62.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.17 -1.048 . . . . 0.44 108.17 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -52.22 -42.09 63.27 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.863 -1.162 . . . . 1.29 107.863 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -56.78 -43.66 81.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.119 -0.988 . . . . 3.1899999999999999 108.666 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.3 mmt -63.28 -42.12 99.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 1.8100000000000001 110.274 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 129' ' ' ASP . 2.7 mp -68.57 -44.06 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.044 -1.035 . . . . 0.089999999999999997 109.247 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -61.87 -43.4 98.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -0.986 . . . . 4.4199999999999999 110.066 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -66.08 -39.24 89.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.011 -1.056 . . . . 1.95 109.418 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.34 -20.07 27.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.208 -0.932 . . . . 0.11 110.458 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 125' ' ' ILE . 61.7 t0 -82.12 101.25 10.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.984 -1.073 . . . . 1.9299999999999999 109.293 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 98.4 mt -90.2 -28.94 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.723 -0.611 . . . . 0.45000000000000001 111.156 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -87.85 1.39 54.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.695 -1.253 . . . . 1.1499999999999999 109.797 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.33 76.69 0.22 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.786 -1.325 . . . . 1.1499999999999999 109.786 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 37.8 p-10 -133.64 -14.58 2.49 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -1.097 . . . . 2.4900000000000002 108.625 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 88.12 9.3 70.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.454 -1.058 . . . . 0.31 110.454 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -141.45 161.43 37.91 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.149 -1.206 . . . . 1.71 109.537 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.11 126.28 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.251 -0.906 . . . . 0.34999999999999998 110.209 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.548 HD21 ' CD ' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -97.21 177.52 5.54 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.551 -0.907 . . . . 2.4500000000000002 108.551 178.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.52 -47.04 87.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 1.1599999999999999 111.081 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -58.22 -46.26 86.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.314 -1.491 . . . . 2.8999999999999999 109.877 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.548 ' CD ' HD21 ' A' ' 137' ' ' ASN . 95.8 mt-10 -66.25 -39.06 89.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 2.77 109.674 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 34.5 t80 -61.34 -43.65 98.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.245 -0.909 . . . . 0.38 109.136 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.53 -50.59 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.393 -0.817 . . . . 0.40000000000000002 109.61 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.24 -41.78 89.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.749 -1.22 . . . . 1.5700000000000001 109.837 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 144' ' ' MET . 14.1 tmm? -67.38 -37.19 82.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.79000000000000004 110.575 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.07 -1.019 . . . . 0.35999999999999999 110.919 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.99 -46.37 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.179 -0.951 . . . . 1.0 109.651 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -63.6 -45.69 89.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.028 . . . . 1.0 109.2 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 91' ' ' VAL . 83.0 tt0 -59.65 -46.57 88.63 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.904 -1.122 . . . . 1.0 108.789 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.61 95.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.992 . . . . 1.0 108.494 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.55 -40.68 97.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.111 -0.993 . . . . 1.0 109.305 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -71.39 -34.09 70.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.995 -1.066 . . . . 1.0 109.214 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 87' ' ' GLU . 62.2 t -67.74 -33.62 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.029 . . . . 1.0 109.484 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 4.4 m-30 -80.74 -28.2 36.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.904 -1.122 . . . . 1.0 108.743 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.507 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 2.5 t70 -76.73 74.59 3.39 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -55.04 -40.18 69.97 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.389 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -89.98 -1.55 57.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.919 -1.113 . . . . 1.0 110.519 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.38 22.02 70.87 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.885 -1.15 . . . . 1.0 110.306 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.507 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 48.3 p-10 -75.67 -3.81 36.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -1.092 . . . . 1.0 110.249 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.41 7.85 88.19 Favored Glycine 0 N--CA 1.49 2.261 0 O-C-N 120.665 -1.272 . . . . 1.0 111.006 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 45.9 m-85 -141.36 135.65 30.69 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.097 -1.237 . . . . 1.0 109.623 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.8 mt -93.31 125.78 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.222 -0.924 . . . . 1.0 109.399 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.0 t -90.26 158.8 17.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.76 . . . . 1.0 109.377 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.465 ' HA ' HD11 ' A' ' 125' ' ' ILE . . . -56.87 -43.67 81.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.371 -0.831 . . . . 1.0 109.612 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.22 -32.65 74.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.965 . . . . 1.0 109.254 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -67.37 -38.56 84.94 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.78 -34.36 77.74 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.913 -1.143 . . . . 1.0 107.913 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -66.97 -34.54 77.99 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.523 -0.735 . . . . 1.0 109.068 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -68.14 -53.64 23.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.317 -0.865 . . . . 1.0 109.811 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.486 HG23 ' N ' ' A' ' 109' ' ' MET . 3.1 m -65.61 -46.27 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.92 -1.113 . . . . 1.0 110.003 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.486 ' N ' HG23 ' A' ' 108' ' ' VAL . 14.2 mmt -65.69 -39.73 91.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 1.0 110.554 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.9 m -64.72 -45.47 86.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 1.0 110.752 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -76.39 -26.45 55.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.719 -1.238 . . . . 1.0 110.108 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.0 mt -68.52 -2.74 9.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 1.0 109.726 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.71 -5.77 56.91 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.118 -1.193 . . . . 1.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 109' ' ' MET . 70.1 mm-40 -102.05 115.44 30.55 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.231 -1.158 . . . . 1.0 108.044 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.425 ' C ' HD12 ' A' ' 116' ' ' LEU . 37.9 tptt -101.54 105.51 16.49 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.87 -1.144 . . . . 1.0 109.16 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 116' ' ' LEU . 10.0 mp -102.73 145.23 30.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 1.0 109.403 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.6 p -81.07 166.21 20.94 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -57.49 -34.31 68.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.864 -1.147 . . . . 1.0 109.475 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 42.0 mp0 -74.39 -39.48 62.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.938 -1.101 . . . . 1.0 109.178 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.71 -38.66 91.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.95 . . . . 1.0 108.678 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.9 t -71.71 -36.51 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 107.566 -1.272 . . . . 1.0 107.566 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.3 -44.86 92.48 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.538 -1.282 . . . . 1.0 107.538 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.427 ' O ' ' OE2' ' A' ' 127' ' ' GLU . 85.8 tt0 -56.85 -46.75 81.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 1.0 108.959 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.0 mtt -65.02 -41.42 95.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 1.0 109.744 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 129' ' ' ASP . 5.8 mm -66.1 -48.5 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.812 . . . . 1.0 109.843 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -62.09 -39.73 93.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 1.0 109.939 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -69.39 -40.25 77.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.001 -1.062 . . . . 1.0 109.27 -179.374 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.24 -21.76 28.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.07 -1.019 . . . . 1.0 110.257 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 125' ' ' ILE . 33.2 t0 -82.72 103.54 12.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.118 -0.989 . . . . 1.0 109.158 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 98.5 mt -87.99 -28.63 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.502 -0.749 . . . . 1.0 111.024 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 47.5 p30 -87.68 2.79 50.1 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.546 -1.346 . . . . 1.0 109.573 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.64 18.26 51.52 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.163 -1.175 . . . . 1.0 110.163 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 23.2 p-10 -71.57 -11.49 60.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.938 -1.331 . . . . 1.0 109.162 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.44 77.4 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.281 -1.128 . . . . 1.0 110.281 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -140.11 163.55 32.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.24 -1.153 . . . . 1.0 109.222 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.02 124.18 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.297 -0.877 . . . . 1.0 109.667 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -95.24 179.25 5.25 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 142' ' ' VAL . 53.5 t80 -59.95 -45.7 91.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 1.0 110.885 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -58.87 -46.28 88.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.469 -1.394 . . . . 1.0 109.949 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.55 -36.46 82.73 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.4 -0.812 . . . . 1.0 109.313 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.03 -43.53 98.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.408 -0.807 . . . . 1.0 109.089 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 138' ' ' TYR . 98.0 t -62.06 -51.0 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.102 -0.999 . . . . 1.0 109.443 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -59.28 -42.75 91.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.859 -1.15 . . . . 1.0 110.02 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . 0.547 ' SD ' ' SD ' ' A' ' 145' ' ' MET . 1.0 OUTLIER -65.58 -35.35 80.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 1.0 110.482 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.547 ' SD ' ' SD ' ' A' ' 144' ' ' MET . 71.7 mmm . . . . . 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 1.0 110.405 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.01 -39.79 93.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.637 -1.289 . . . . 1.0 109.05 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -61.61 -43.52 98.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 1.0 108.587 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.42 HG21 HG22 ' A' ' 142' ' ' VAL . 69.8 mt -69.27 -43.47 81.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.303 -0.873 . . . . 1.0 109.524 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' A' ' 86' ' ' ARG . 0.4 OUTLIER -65.08 -50.39 66.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 1.0 109.362 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -58.26 -44.96 88.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.878 -1.139 . . . . 1.0 108.412 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.61 97.62 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -62.9 -40.22 96.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.027 -1.045 . . . . 1.0 109.279 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.605 HH21 ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -69.72 -32.74 71.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.937 -1.102 . . . . 1.0 108.996 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.46 -36.69 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.949 . . . . 1.0 109.879 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 108' ' ' VAL . 3.2 m-85 -79.76 -25.93 40.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.966 -1.084 . . . . 1.0 109.606 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 98' ' ' GLY . 53.8 t0 -79.74 74.26 6.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 1.0 108.556 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.489 ' HZ1' HG22 ' A' ' 108' ' ' VAL . 12.1 mptt -54.14 -38.74 65.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.873 -0.517 . . . . 1.0 110.798 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 9.4 p30 -88.31 -4.9 58.61 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.121 -0.987 . . . . 1.0 110.952 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.605 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . 67.63 23.1 73.78 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.599 -1.286 . . . . 1.0 110.187 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.486 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 50.5 p-10 -76.69 -3.06 36.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -1.14 . . . . 1.0 110.73 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.433 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 79.34 5.17 89.24 Favored Glycine 0 N--CA 1.489 2.193 0 O-C-N 120.591 -1.318 . . . . 1.0 110.538 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 31.3 m-85 -139.44 138.84 36.8 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.303 -1.116 . . . . 1.0 109.822 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.0 mt -96.31 122.24 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 1.0 109.06 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 t -84.78 158.97 20.55 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.509 0.671 . . . . 1.0 109.575 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.71 90.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.342 -0.849 . . . . 1.0 109.698 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.429 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -63.53 -33.65 76.06 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.144 -0.972 . . . . 1.0 109.274 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -65.48 -36.58 84.3 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 tp -63.62 -38.22 90.3 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.404 -0.961 . . . . 1.0 108.404 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.568 ' O ' HG23 ' A' ' 110' ' ' THR . 33.9 mtm180 -64.07 -36.2 83.23 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -65.73 -50.51 64.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 1.0 109.267 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.489 HG22 ' HZ1' ' A' ' 94' ' ' LYS . 22.9 t -65.95 -47.43 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.958 . . . . 1.0 110.349 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.594 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -65.98 -41.4 91.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.368 -0.833 . . . . 1.0 110.742 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 106' ' ' ARG . 35.6 p -65.05 -45.75 84.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -0.99 . . . . 1.0 110.619 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -76.68 -28.64 56.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.799 -1.188 . . . . 1.0 109.836 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.33 -5.99 21.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 1.0 109.13 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.33 -5.76 49.31 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 110.103 -1.199 . . . . 1.0 110.103 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.492 ' O ' ' O ' ' A' ' 109' ' ' MET . 94.7 mt-10 -99.97 114.88 28.46 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.135 -1.215 . . . . 1.0 108.247 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -101.75 102.86 13.56 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.893 -1.13 . . . . 1.0 108.966 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.0 mt -104.36 148.13 26.74 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.698 0.761 . . . . 1.0 109.907 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.7 p -84.93 165.18 17.85 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.042 -1.096 . . . . 1.0 108.042 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -57.58 -31.94 66.67 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.868 -1.145 . . . . 1.0 109.678 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -74.84 -41.34 60.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.953 -1.092 . . . . 1.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -60.86 -38.01 84.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.088 -1.008 . . . . 1.0 108.76 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.55 -35.68 51.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.689 -1.226 . . . . 1.0 107.689 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.546 ' C ' ' HE ' ' A' ' 126' ' ' ARG . 46.8 t0 -57.78 -42.28 83.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.426 -1.324 . . . . 1.0 107.426 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.538 ' CA ' HH21 ' A' ' 126' ' ' ARG . 84.4 tt0 -61.7 -46.61 88.96 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.164 -0.96 . . . . 1.0 109.195 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 77.5 mtp -64.67 -42.63 95.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.102 -0.999 . . . . 1.0 109.682 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 129' ' ' ASP . 22.5 mm -65.37 -49.61 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.524 -0.735 . . . . 1.0 109.194 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.546 ' HE ' ' C ' ' A' ' 122' ' ' ASP . 87.6 mtm180 -61.03 -38.17 85.15 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.317 -0.864 . . . . 1.0 109.877 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -72.28 -42.37 65.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.037 -1.039 . . . . 1.0 109.567 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.85 -22.82 31.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.099 -1.0 . . . . 1.0 110.175 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 125' ' ' ILE . 43.8 t0 -81.08 101.56 9.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.142 -0.974 . . . . 1.0 109.16 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 97.4 mt -86.06 -28.07 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.598 -0.689 . . . . 1.0 110.475 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 17.4 p30 -88.98 0.98 56.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.697 -1.252 . . . . 1.0 109.303 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.52 23.46 66.83 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 28.7 p-10 -76.99 -15.81 59.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.027 -1.278 . . . . 1.0 109.471 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.44 10.46 65.6 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -140.97 160.35 40.26 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.109 -1.23 . . . . 1.0 109.427 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.8 t -102.73 123.05 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.229 -0.919 . . . . 1.0 109.908 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.551 HD21 ' CD ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -95.61 173.99 7.21 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.246 -1.02 . . . . 1.0 108.246 178.626 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 142' ' ' VAL . 86.1 t80 -55.39 -47.04 76.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.058 -1.027 . . . . 1.0 110.747 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.623 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 31.1 mp0 -60.05 -45.88 91.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.436 -1.415 . . . . 1.0 110.243 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.551 ' CD ' HD21 ' A' ' 137' ' ' ASN . 94.6 mt-10 -65.53 -39.28 91.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 1.0 109.769 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' SD ' ' A' ' 145' ' ' MET . 30.7 t80 -62.07 -44.3 96.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -0.934 . . . . 1.0 109.265 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 146' ' ' THR . 96.3 t -59.66 -50.56 79.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.107 -0.996 . . . . 1.0 109.281 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -61.86 -42.4 99.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.018 -1.051 . . . . 1.0 110.352 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.472 ' C ' ' SD ' ' A' ' 144' ' ' MET . 1.1 tmt? -64.36 -41.5 96.7 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.953 -1.092 . . . . 1.0 110.448 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 141' ' ' PHE . 2.0 mpt? -91.01 -22.64 20.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.795 -1.19 . . . . 1.0 110.192 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 142' ' ' VAL . 2.5 m -109.9 24.14 13.43 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 108.439 -0.948 . . . . 1.0 108.439 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.69 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.029 -1.045 . . . . 1.0 109.301 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 146' ' ' THR . 4.9 tmtt? . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 1.0 109.166 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1000 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1001 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.712 0.768 . . . . 1.97 109.477 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -71.54 -36.01 70.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.667 -0.646 . . . . 2.2200000000000002 110.096 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -62.83 -54.25 41.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.883 -1.136 . . . . 2.2799999999999998 109.381 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CG1' ' N ' ' A' ' 86' ' ' ARG . 6.4 pt -68.12 -43.51 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.967 . . . . 0.29999999999999999 109.801 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.421 ' N ' ' CG1' ' A' ' 85' ' ' ILE . 65.3 ttt180 -65.13 -46.32 81.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.037 . . . . 2.7200000000000002 109.737 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -57.24 -45.57 83.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.884 -1.135 . . . . 3.0499999999999998 108.388 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.513 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.05 -41.38 92.19 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.011 -1.107 . . . . 0.070000000000000007 108.011 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.43 -39.93 94.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.121 -0.987 . . . . 0.11 109.31 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' A' ' 90' ' ' ARG . 0.0 OUTLIER -71.64 -34.53 69.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 4.6900000000000004 108.793 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.5 t -65.19 -38.33 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.11 109.44 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 9.8 m-85 -78.11 -28.16 48.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -0.998 . . . . 0.20999999999999999 109.239 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 57.6 t0 -79.19 75.69 5.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.059 -1.026 . . . . 1.46 108.464 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -54.82 -38.21 67.08 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 116.055 -0.52 . . . . 3.98 111.438 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.424 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 20.0 p30 -89.92 -2.97 58.28 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.837 -1.164 . . . . 3.1000000000000001 110.857 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.525 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . 65.58 24.01 70.8 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.984 -1.103 . . . . 0.46000000000000002 111.031 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.819 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -79.54 1.19 26.77 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.08 -1.247 . . . . 1.3100000000000001 110.387 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.627 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 78.46 -0.68 74.69 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.627 -1.296 . . . . 0.23000000000000001 110.911 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.819 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 22.7 m-85 -135.26 141.0 45.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.417 -1.049 . . . . 0.81000000000000005 109.941 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.5 mt -100.57 127.38 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.415 -0.803 . . . . 0.31 109.363 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 p -87.46 160.0 18.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.738 . . . . 0.20999999999999999 109.322 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.2 93.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.32 -0.863 . . . . 0.11 109.671 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.08 74.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.158 -0.963 . . . . 0.12 108.952 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -66.46 -36.19 82.15 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.364 -1.347 . . . . 0.81000000000000005 107.364 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.0 tp -63.51 -34.44 77.79 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.607 -1.257 . . . . 0.16 107.607 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.513 ' NH1' ' OD1' ' A' ' 118' ' ' ASP . 61.3 ttt180 -67.6 -35.13 78.39 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.586 -0.697 . . . . 3.52 109.284 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -67.74 -53.13 29.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.359 -0.838 . . . . 0.48999999999999999 109.652 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 109' ' ' MET . 5.2 m -66.68 -45.65 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.088 . . . . 0.10000000000000001 109.68 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.518 ' N ' HG23 ' A' ' 108' ' ' VAL . 14.5 mmt -65.3 -39.52 92.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.12 110.257 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 53.0 m -65.68 -43.39 89.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.889 . . . . 0.17999999999999999 110.525 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -79.72 -29.29 40.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.841 -1.162 . . . . 1.1200000000000001 110.253 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.07 -1.74 1.06 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.95 -1.094 . . . . 0.45000000000000001 109.753 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.61 -8.52 60.1 Favored Glycine 0 N--CA 1.499 2.884 0 N-CA-C 110.079 -1.208 . . . . 0.40999999999999998 110.079 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 109' ' ' MET . 94.2 mt-10 -94.88 120.03 34.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.089 -1.242 . . . . 2.29 108.119 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -105.8 100.05 9.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.126 -0.984 . . . . 1.51 109.06 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.1 mt -105.84 149.9 26.09 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.656 0.741 . . . . 3.77 109.857 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.9 p -83.0 166.13 19.07 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.261 -1.014 . . . . 0.29999999999999999 108.261 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.513 ' OD1' ' NH1' ' A' ' 106' ' ' ARG . 81.6 m-20 -58.12 -36.45 72.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.943 -1.098 . . . . 1.6000000000000001 109.855 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -71.01 -39.89 72.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.826 -1.171 . . . . 1.75 109.15 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.7 -38.48 91.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.465 -0.939 . . . . 0.68000000000000005 108.465 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.1 t -70.48 -47.88 62.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.17 -1.048 . . . . 0.44 108.17 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -52.22 -42.09 63.27 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.863 -1.162 . . . . 1.29 107.863 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -56.78 -43.66 81.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.119 -0.988 . . . . 3.1899999999999999 108.666 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.3 mmt -63.28 -42.12 99.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 1.8100000000000001 110.274 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 129' ' ' ASP . 2.7 mp -68.57 -44.06 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.044 -1.035 . . . . 0.089999999999999997 109.247 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -61.87 -43.4 98.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -0.986 . . . . 4.4199999999999999 110.066 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -66.08 -39.24 89.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.011 -1.056 . . . . 1.95 109.418 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.34 -20.07 27.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.208 -0.932 . . . . 0.11 110.458 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 125' ' ' ILE . 61.7 t0 -82.12 101.25 10.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.984 -1.073 . . . . 1.9299999999999999 109.293 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 98.4 mt -90.2 -28.94 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.723 -0.611 . . . . 0.45000000000000001 111.156 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -87.85 1.39 54.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.695 -1.253 . . . . 1.1499999999999999 109.797 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.33 76.69 0.22 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.786 -1.325 . . . . 1.1499999999999999 109.786 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 37.8 p-10 -133.64 -14.58 2.49 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -1.097 . . . . 2.4900000000000002 108.625 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 88.12 9.3 70.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.454 -1.058 . . . . 0.31 110.454 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -141.45 161.43 37.91 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.149 -1.206 . . . . 1.71 109.537 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.11 126.28 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.251 -0.906 . . . . 0.34999999999999998 110.209 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.548 HD21 ' CD ' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -97.21 177.52 5.54 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.551 -0.907 . . . . 2.4500000000000002 108.551 178.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.52 -47.04 87.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 1.1599999999999999 111.081 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -58.22 -46.26 86.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.314 -1.491 . . . . 2.8999999999999999 109.877 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.548 ' CD ' HD21 ' A' ' 137' ' ' ASN . 95.8 mt-10 -66.25 -39.06 89.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 2.77 109.674 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 34.5 t80 -61.34 -43.65 98.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.245 -0.909 . . . . 0.38 109.136 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 146' ' ' THR . 95.0 t -61.53 -50.59 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.393 -0.817 . . . . 0.40000000000000002 109.61 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.24 -41.78 89.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.749 -1.22 . . . . 1.5700000000000001 109.837 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 144' ' ' MET . 14.1 tmm? -67.38 -37.19 82.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.79000000000000004 110.575 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -93.17 -28.49 16.26 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.07 -1.019 . . . . 0.35999999999999999 110.919 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 142' ' ' VAL . 38.6 m -52.56 -48.64 66.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.81999999999999995 109.249 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 46.86 -140.64 0.49 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 1.28 109.747 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.421 ' HZ2' ' HB3' ' A' ' 148' ' ' LYS . 1.2 ptpp? . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 2.2599999999999998 109.463 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1000 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 1001 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.603 -0.517 . . . . 1.0 109.603 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -63.51 -36.91 85.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.931 -1.106 . . . . 1.0 108.213 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.99 -38.85 89.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.399 -0.813 . . . . 1.0 109.284 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.99 -46.37 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.179 -0.951 . . . . 1.0 109.651 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -63.6 -45.69 89.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.028 . . . . 1.0 109.2 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 91' ' ' VAL . 83.0 tt0 -59.65 -46.57 88.63 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.904 -1.122 . . . . 1.0 108.789 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.61 95.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.992 . . . . 1.0 108.494 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.55 -40.68 97.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.111 -0.993 . . . . 1.0 109.305 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -71.39 -34.09 70.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.995 -1.066 . . . . 1.0 109.214 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 87' ' ' GLU . 62.2 t -67.74 -33.62 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.029 . . . . 1.0 109.484 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 4.4 m-30 -80.74 -28.2 36.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.904 -1.122 . . . . 1.0 108.743 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.507 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 2.5 t70 -76.73 74.59 3.39 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -55.04 -40.18 69.97 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.389 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -89.98 -1.55 57.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.919 -1.113 . . . . 1.0 110.519 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.38 22.02 70.87 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.885 -1.15 . . . . 1.0 110.306 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.507 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 48.3 p-10 -75.67 -3.81 36.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -1.092 . . . . 1.0 110.249 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.41 7.85 88.19 Favored Glycine 0 N--CA 1.49 2.261 0 O-C-N 120.665 -1.272 . . . . 1.0 111.006 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 45.9 m-85 -141.36 135.65 30.69 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.097 -1.237 . . . . 1.0 109.623 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.8 mt -93.31 125.78 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.222 -0.924 . . . . 1.0 109.399 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.0 t -90.26 158.8 17.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.76 . . . . 1.0 109.377 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.465 ' HA ' HD11 ' A' ' 125' ' ' ILE . . . -56.87 -43.67 81.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.371 -0.831 . . . . 1.0 109.612 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.22 -32.65 74.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.965 . . . . 1.0 109.254 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -67.37 -38.56 84.94 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.78 -34.36 77.74 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.913 -1.143 . . . . 1.0 107.913 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -66.97 -34.54 77.99 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.523 -0.735 . . . . 1.0 109.068 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -68.14 -53.64 23.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.317 -0.865 . . . . 1.0 109.811 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.486 HG23 ' N ' ' A' ' 109' ' ' MET . 3.1 m -65.61 -46.27 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.92 -1.113 . . . . 1.0 110.003 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.486 ' N ' HG23 ' A' ' 108' ' ' VAL . 14.2 mmt -65.69 -39.73 91.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 1.0 110.554 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.9 m -64.72 -45.47 86.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 1.0 110.752 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -76.39 -26.45 55.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.719 -1.238 . . . . 1.0 110.108 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.0 mt -68.52 -2.74 9.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 1.0 109.726 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.71 -5.77 56.91 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.118 -1.193 . . . . 1.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 109' ' ' MET . 70.1 mm-40 -102.05 115.44 30.55 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.231 -1.158 . . . . 1.0 108.044 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' C ' HD12 ' A' ' 116' ' ' LEU . 37.9 tptt -101.54 105.51 16.49 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.87 -1.144 . . . . 1.0 109.16 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 116' ' ' LEU . 10.0 mp -102.73 145.23 30.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 1.0 109.403 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.6 p -81.07 166.21 20.94 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -57.49 -34.31 68.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.864 -1.147 . . . . 1.0 109.475 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 42.0 mp0 -74.39 -39.48 62.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.938 -1.101 . . . . 1.0 109.178 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.71 -38.66 91.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.95 . . . . 1.0 108.678 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.9 t -71.71 -36.51 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 107.566 -1.272 . . . . 1.0 107.566 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.3 -44.86 92.48 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.538 -1.282 . . . . 1.0 107.538 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.427 ' O ' ' OE2' ' A' ' 127' ' ' GLU . 85.8 tt0 -56.85 -46.75 81.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 1.0 108.959 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.0 mtt -65.02 -41.42 95.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 1.0 109.744 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 129' ' ' ASP . 5.8 mm -66.1 -48.5 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.812 . . . . 1.0 109.843 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -62.09 -39.73 93.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 1.0 109.939 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -69.39 -40.25 77.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.001 -1.062 . . . . 1.0 109.27 -179.374 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.24 -21.76 28.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.07 -1.019 . . . . 1.0 110.257 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 125' ' ' ILE . 33.2 t0 -82.72 103.54 12.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.118 -0.989 . . . . 1.0 109.158 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 98.5 mt -87.99 -28.63 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.502 -0.749 . . . . 1.0 111.024 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 47.5 p30 -87.68 2.79 50.1 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.546 -1.346 . . . . 1.0 109.573 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.64 18.26 51.52 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.163 -1.175 . . . . 1.0 110.163 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 23.2 p-10 -71.57 -11.49 60.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.938 -1.331 . . . . 1.0 109.162 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.44 77.4 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.281 -1.128 . . . . 1.0 110.281 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -140.11 163.55 32.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.24 -1.153 . . . . 1.0 109.222 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.02 124.18 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.297 -0.877 . . . . 1.0 109.667 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -95.24 179.25 5.25 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 142' ' ' VAL . 53.5 t80 -59.95 -45.7 91.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 1.0 110.885 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -58.87 -46.28 88.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.469 -1.394 . . . . 1.0 109.949 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.55 -36.46 82.73 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.4 -0.812 . . . . 1.0 109.313 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.03 -43.53 98.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.408 -0.807 . . . . 1.0 109.089 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 146' ' ' THR . 98.0 t -62.06 -51.0 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.102 -0.999 . . . . 1.0 109.443 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -59.28 -42.75 91.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.859 -1.15 . . . . 1.0 110.02 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . 0.547 ' SD ' ' SD ' ' A' ' 145' ' ' MET . 1.0 OUTLIER -65.58 -35.35 80.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 1.0 110.482 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.547 ' SD ' ' SD ' ' A' ' 144' ' ' MET . 71.7 mmm -93.03 -25.16 18.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 1.0 110.405 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 142' ' ' VAL . 27.1 p -113.74 25.54 11.13 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.13 140.27 21.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.063 -1.023 . . . . 1.0 109.244 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.7 mttp . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 1.0 109.482 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1000 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 1001 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 108.587 -0.894 . . . . 1.0 108.587 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.42 HG21 HG22 ' A' ' 142' ' ' VAL . 69.8 mt -69.27 -43.47 81.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.303 -0.873 . . . . 1.0 109.524 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' A' ' 86' ' ' ARG . 0.4 OUTLIER -65.08 -50.39 66.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 1.0 109.362 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -58.26 -44.96 88.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.878 -1.139 . . . . 1.0 108.412 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.61 97.62 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -62.9 -40.22 96.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.027 -1.045 . . . . 1.0 109.279 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.605 HH21 ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -69.72 -32.74 71.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.937 -1.102 . . . . 1.0 108.996 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.46 -36.69 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.949 . . . . 1.0 109.879 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 108' ' ' VAL . 3.2 m-85 -79.76 -25.93 40.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.966 -1.084 . . . . 1.0 109.606 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 98' ' ' GLY . 53.8 t0 -79.74 74.26 6.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 1.0 108.556 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.489 ' HZ1' HG22 ' A' ' 108' ' ' VAL . 12.1 mptt -54.14 -38.74 65.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.873 -0.517 . . . . 1.0 110.798 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 9.4 p30 -88.31 -4.9 58.61 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.121 -0.987 . . . . 1.0 110.952 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.605 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . 67.63 23.1 73.78 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.599 -1.286 . . . . 1.0 110.187 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.486 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 50.5 p-10 -76.69 -3.06 36.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -1.14 . . . . 1.0 110.73 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.433 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 79.34 5.17 89.24 Favored Glycine 0 N--CA 1.489 2.193 0 O-C-N 120.591 -1.318 . . . . 1.0 110.538 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 31.3 m-85 -139.44 138.84 36.8 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.303 -1.116 . . . . 1.0 109.822 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.0 mt -96.31 122.24 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 1.0 109.06 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 t -84.78 158.97 20.55 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.509 0.671 . . . . 1.0 109.575 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.71 90.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.342 -0.849 . . . . 1.0 109.698 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.429 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -63.53 -33.65 76.06 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.144 -0.972 . . . . 1.0 109.274 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -65.48 -36.58 84.3 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 tp -63.62 -38.22 90.3 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.404 -0.961 . . . . 1.0 108.404 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.568 ' O ' HG23 ' A' ' 110' ' ' THR . 33.9 mtm180 -64.07 -36.2 83.23 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -65.73 -50.51 64.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 1.0 109.267 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.489 HG22 ' HZ1' ' A' ' 94' ' ' LYS . 22.9 t -65.95 -47.43 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.958 . . . . 1.0 110.349 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.594 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -65.98 -41.4 91.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.368 -0.833 . . . . 1.0 110.742 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 106' ' ' ARG . 35.6 p -65.05 -45.75 84.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -0.99 . . . . 1.0 110.619 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -76.68 -28.64 56.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.799 -1.188 . . . . 1.0 109.836 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.33 -5.99 21.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 1.0 109.13 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.33 -5.76 49.31 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 110.103 -1.199 . . . . 1.0 110.103 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.492 ' O ' ' O ' ' A' ' 109' ' ' MET . 94.7 mt-10 -99.97 114.88 28.46 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.135 -1.215 . . . . 1.0 108.247 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -101.75 102.86 13.56 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.893 -1.13 . . . . 1.0 108.966 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.0 mt -104.36 148.13 26.74 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.698 0.761 . . . . 1.0 109.907 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.7 p -84.93 165.18 17.85 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.042 -1.096 . . . . 1.0 108.042 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -57.58 -31.94 66.67 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.868 -1.145 . . . . 1.0 109.678 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -74.84 -41.34 60.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.953 -1.092 . . . . 1.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -60.86 -38.01 84.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.088 -1.008 . . . . 1.0 108.76 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.55 -35.68 51.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.689 -1.226 . . . . 1.0 107.689 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.546 ' C ' ' HE ' ' A' ' 126' ' ' ARG . 46.8 t0 -57.78 -42.28 83.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.426 -1.324 . . . . 1.0 107.426 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.538 ' CA ' HH21 ' A' ' 126' ' ' ARG . 84.4 tt0 -61.7 -46.61 88.96 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.164 -0.96 . . . . 1.0 109.195 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 77.5 mtp -64.67 -42.63 95.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.102 -0.999 . . . . 1.0 109.682 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 129' ' ' ASP . 22.5 mm -65.37 -49.61 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.524 -0.735 . . . . 1.0 109.194 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.546 ' HE ' ' C ' ' A' ' 122' ' ' ASP . 87.6 mtm180 -61.03 -38.17 85.15 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.317 -0.864 . . . . 1.0 109.877 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -72.28 -42.37 65.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.037 -1.039 . . . . 1.0 109.567 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.85 -22.82 31.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.099 -1.0 . . . . 1.0 110.175 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 125' ' ' ILE . 43.8 t0 -81.08 101.56 9.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.142 -0.974 . . . . 1.0 109.16 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 97.4 mt -86.06 -28.07 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.598 -0.689 . . . . 1.0 110.475 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 17.4 p30 -88.98 0.98 56.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.697 -1.252 . . . . 1.0 109.303 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.52 23.46 66.83 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 28.7 p-10 -76.99 -15.81 59.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.027 -1.278 . . . . 1.0 109.471 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.44 10.46 65.6 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -140.97 160.35 40.26 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.109 -1.23 . . . . 1.0 109.427 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.8 t -102.73 123.05 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.229 -0.919 . . . . 1.0 109.908 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.551 HD21 ' CD ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -95.61 173.99 7.21 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.246 -1.02 . . . . 1.0 108.246 178.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 142' ' ' VAL . 86.1 t80 -55.39 -47.04 76.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.058 -1.027 . . . . 1.0 110.747 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.623 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 31.1 mp0 -60.05 -45.88 91.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.436 -1.415 . . . . 1.0 110.243 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.551 ' CD ' HD21 ' A' ' 137' ' ' ASN . 94.6 mt-10 -65.53 -39.28 91.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 1.0 109.769 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' SD ' ' A' ' 145' ' ' MET . 30.7 t80 -62.07 -44.3 96.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -0.934 . . . . 1.0 109.265 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 138' ' ' TYR . 96.3 t -59.66 -50.56 79.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.107 -0.996 . . . . 1.0 109.281 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -61.86 -42.4 99.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.018 -1.051 . . . . 1.0 110.352 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.472 ' C ' ' SD ' ' A' ' 144' ' ' MET . 1.1 tmt? -64.36 -41.5 96.7 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.953 -1.092 . . . . 1.0 110.448 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 141' ' ' PHE . 2.0 mpt? . . . . . 0 N--CA 1.497 1.884 0 O-C-N 120.795 -1.19 . . . . 1.0 110.192 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.381 -0.599 . . . . 2.2799999999999998 109.381 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CG1' ' N ' ' A' ' 86' ' ' ARG . 6.4 pt -68.12 -43.51 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.967 . . . . 0.29999999999999999 109.801 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.421 ' N ' ' CG1' ' A' ' 85' ' ' ILE . 65.3 ttt180 -65.13 -46.32 81.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.037 . . . . 2.7200000000000002 109.737 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -57.24 -45.57 83.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.884 -1.135 . . . . 3.0499999999999998 108.388 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.513 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.05 -41.38 92.19 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.011 -1.107 . . . . 0.070000000000000007 108.011 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.43 -39.93 94.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.121 -0.987 . . . . 0.11 109.31 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' A' ' 90' ' ' ARG . 0.0 OUTLIER -71.64 -34.53 69.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 4.6900000000000004 108.793 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.5 t -65.19 -38.33 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.11 109.44 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 9.8 m-85 -78.11 -28.16 48.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -0.998 . . . . 0.20999999999999999 109.239 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 57.6 t0 -79.19 75.69 5.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.059 -1.026 . . . . 1.46 108.464 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -54.82 -38.21 67.08 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 116.055 -0.52 . . . . 3.98 111.438 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.424 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 20.0 p30 -89.92 -2.97 58.28 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.837 -1.164 . . . . 3.1000000000000001 110.857 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.525 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . 65.58 24.01 70.8 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.984 -1.103 . . . . 0.46000000000000002 111.031 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.819 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -79.54 1.19 26.77 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.08 -1.247 . . . . 1.3100000000000001 110.387 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.627 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 78.46 -0.68 74.69 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.627 -1.296 . . . . 0.23000000000000001 110.911 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.819 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 22.7 m-85 -135.26 141.0 45.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.417 -1.049 . . . . 0.81000000000000005 109.941 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.5 mt -100.57 127.38 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.415 -0.803 . . . . 0.31 109.363 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 p -87.46 160.0 18.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.738 . . . . 0.20999999999999999 109.322 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.2 93.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.32 -0.863 . . . . 0.11 109.671 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.08 74.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.158 -0.963 . . . . 0.12 108.952 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -66.46 -36.19 82.15 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.364 -1.347 . . . . 0.81000000000000005 107.364 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.0 tp -63.51 -34.44 77.79 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.607 -1.257 . . . . 0.16 107.607 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.513 ' NH1' ' OD1' ' A' ' 118' ' ' ASP . 61.3 ttt180 -67.6 -35.13 78.39 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.586 -0.697 . . . . 3.52 109.284 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -67.74 -53.13 29.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.359 -0.838 . . . . 0.48999999999999999 109.652 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 109' ' ' MET . 5.2 m -66.68 -45.65 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.088 . . . . 0.10000000000000001 109.68 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.518 ' N ' HG23 ' A' ' 108' ' ' VAL . 14.5 mmt -65.3 -39.52 92.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.12 110.257 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 53.0 m -65.68 -43.39 89.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.889 . . . . 0.17999999999999999 110.525 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -79.72 -29.29 40.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.841 -1.162 . . . . 1.1200000000000001 110.253 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.07 -1.74 1.06 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.95 -1.094 . . . . 0.45000000000000001 109.753 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.61 -8.52 60.1 Favored Glycine 0 N--CA 1.499 2.884 0 N-CA-C 110.079 -1.208 . . . . 0.40999999999999998 110.079 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 109' ' ' MET . 94.2 mt-10 -94.88 120.03 34.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.089 -1.242 . . . . 2.29 108.119 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -105.8 100.05 9.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.126 -0.984 . . . . 1.51 109.06 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.1 mt -105.84 149.9 26.09 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.656 0.741 . . . . 3.77 109.857 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.9 p -83.0 166.13 19.07 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.261 -1.014 . . . . 0.29999999999999999 108.261 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.513 ' OD1' ' NH1' ' A' ' 106' ' ' ARG . 81.6 m-20 -58.12 -36.45 72.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.943 -1.098 . . . . 1.6000000000000001 109.855 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -71.01 -39.89 72.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.826 -1.171 . . . . 1.75 109.15 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.7 -38.48 91.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.465 -0.939 . . . . 0.68000000000000005 108.465 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.1 t -70.48 -47.88 62.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.17 -1.048 . . . . 0.44 108.17 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -52.22 -42.09 63.27 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.863 -1.162 . . . . 1.29 107.863 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -56.78 -43.66 81.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.119 -0.988 . . . . 3.1899999999999999 108.666 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.3 mmt -63.28 -42.12 99.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 1.8100000000000001 110.274 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 129' ' ' ASP . 2.7 mp -68.57 -44.06 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.044 -1.035 . . . . 0.089999999999999997 109.247 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -61.87 -43.4 98.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -0.986 . . . . 4.4199999999999999 110.066 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -66.08 -39.24 89.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.011 -1.056 . . . . 1.95 109.418 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.34 -20.07 27.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.208 -0.932 . . . . 0.11 110.458 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 125' ' ' ILE . 61.7 t0 -82.12 101.25 10.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.984 -1.073 . . . . 1.9299999999999999 109.293 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 98.4 mt -90.2 -28.94 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.723 -0.611 . . . . 0.45000000000000001 111.156 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -87.85 1.39 54.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.695 -1.253 . . . . 1.1499999999999999 109.797 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.33 76.69 0.22 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.786 -1.325 . . . . 1.1499999999999999 109.786 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 37.8 p-10 -133.64 -14.58 2.49 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -1.097 . . . . 2.4900000000000002 108.625 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 88.12 9.3 70.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.454 -1.058 . . . . 0.31 110.454 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -141.45 161.43 37.91 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.149 -1.206 . . . . 1.71 109.537 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.11 126.28 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.251 -0.906 . . . . 0.34999999999999998 110.209 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.548 HD21 ' CD ' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -97.21 177.52 5.54 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.551 -0.907 . . . . 2.4500000000000002 108.551 178.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.52 -47.04 87.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 1.1599999999999999 111.081 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -58.22 -46.26 86.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.314 -1.491 . . . . 2.8999999999999999 109.877 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.548 ' CD ' HD21 ' A' ' 137' ' ' ASN . 95.8 mt-10 -66.25 -39.06 89.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 2.77 109.674 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 34.5 t80 -61.34 -43.65 98.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.245 -0.909 . . . . 0.38 109.136 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 95.0 t -61.53 -50.59 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.393 -0.817 . . . . 0.40000000000000002 109.61 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.24 -41.78 89.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.749 -1.22 . . . . 1.5700000000000001 109.837 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 144' ' ' MET . 14.1 tmm? -67.38 -37.19 82.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.79000000000000004 110.575 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.07 -1.019 . . . . 0.35999999999999999 110.919 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.284 -0.636 . . . . 1.0 109.284 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.99 -46.37 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.179 -0.951 . . . . 1.0 109.651 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -63.6 -45.69 89.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.028 . . . . 1.0 109.2 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 91' ' ' VAL . 83.0 tt0 -59.65 -46.57 88.63 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.904 -1.122 . . . . 1.0 108.789 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.61 95.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.992 . . . . 1.0 108.494 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.55 -40.68 97.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.111 -0.993 . . . . 1.0 109.305 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -71.39 -34.09 70.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.995 -1.066 . . . . 1.0 109.214 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 87' ' ' GLU . 62.2 t -67.74 -33.62 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.029 . . . . 1.0 109.484 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 4.4 m-30 -80.74 -28.2 36.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.904 -1.122 . . . . 1.0 108.743 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.507 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 2.5 t70 -76.73 74.59 3.39 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -55.04 -40.18 69.97 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.389 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -89.98 -1.55 57.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.919 -1.113 . . . . 1.0 110.519 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.38 22.02 70.87 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.885 -1.15 . . . . 1.0 110.306 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.507 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 48.3 p-10 -75.67 -3.81 36.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -1.092 . . . . 1.0 110.249 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.41 7.85 88.19 Favored Glycine 0 N--CA 1.49 2.261 0 O-C-N 120.665 -1.272 . . . . 1.0 111.006 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 45.9 m-85 -141.36 135.65 30.69 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.097 -1.237 . . . . 1.0 109.623 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.8 mt -93.31 125.78 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.222 -0.924 . . . . 1.0 109.399 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.0 t -90.26 158.8 17.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.76 . . . . 1.0 109.377 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.465 ' HA ' HD11 ' A' ' 125' ' ' ILE . . . -56.87 -43.67 81.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.371 -0.831 . . . . 1.0 109.612 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.22 -32.65 74.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.965 . . . . 1.0 109.254 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -67.37 -38.56 84.94 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.78 -34.36 77.74 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.913 -1.143 . . . . 1.0 107.913 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -66.97 -34.54 77.99 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.523 -0.735 . . . . 1.0 109.068 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -68.14 -53.64 23.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.317 -0.865 . . . . 1.0 109.811 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.486 HG23 ' N ' ' A' ' 109' ' ' MET . 3.1 m -65.61 -46.27 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.92 -1.113 . . . . 1.0 110.003 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.486 ' N ' HG23 ' A' ' 108' ' ' VAL . 14.2 mmt -65.69 -39.73 91.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 1.0 110.554 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.9 m -64.72 -45.47 86.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 1.0 110.752 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -76.39 -26.45 55.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.719 -1.238 . . . . 1.0 110.108 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.0 mt -68.52 -2.74 9.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 1.0 109.726 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.71 -5.77 56.91 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.118 -1.193 . . . . 1.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 109' ' ' MET . 70.1 mm-40 -102.05 115.44 30.55 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.231 -1.158 . . . . 1.0 108.044 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.425 ' C ' HD12 ' A' ' 116' ' ' LEU . 37.9 tptt -101.54 105.51 16.49 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.87 -1.144 . . . . 1.0 109.16 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 116' ' ' LEU . 10.0 mp -102.73 145.23 30.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 1.0 109.403 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.6 p -81.07 166.21 20.94 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -57.49 -34.31 68.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.864 -1.147 . . . . 1.0 109.475 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 42.0 mp0 -74.39 -39.48 62.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.938 -1.101 . . . . 1.0 109.178 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.71 -38.66 91.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.95 . . . . 1.0 108.678 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.9 t -71.71 -36.51 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 107.566 -1.272 . . . . 1.0 107.566 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.3 -44.86 92.48 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.538 -1.282 . . . . 1.0 107.538 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.427 ' O ' ' OE2' ' A' ' 127' ' ' GLU . 85.8 tt0 -56.85 -46.75 81.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 1.0 108.959 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.0 mtt -65.02 -41.42 95.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 1.0 109.744 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 129' ' ' ASP . 5.8 mm -66.1 -48.5 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.812 . . . . 1.0 109.843 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -62.09 -39.73 93.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 1.0 109.939 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -69.39 -40.25 77.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.001 -1.062 . . . . 1.0 109.27 -179.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.24 -21.76 28.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.07 -1.019 . . . . 1.0 110.257 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 125' ' ' ILE . 33.2 t0 -82.72 103.54 12.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.118 -0.989 . . . . 1.0 109.158 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 98.5 mt -87.99 -28.63 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.502 -0.749 . . . . 1.0 111.024 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 47.5 p30 -87.68 2.79 50.1 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.546 -1.346 . . . . 1.0 109.573 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.64 18.26 51.52 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.163 -1.175 . . . . 1.0 110.163 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 23.2 p-10 -71.57 -11.49 60.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.938 -1.331 . . . . 1.0 109.162 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.44 77.4 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.281 -1.128 . . . . 1.0 110.281 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -140.11 163.55 32.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.24 -1.153 . . . . 1.0 109.222 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.02 124.18 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.297 -0.877 . . . . 1.0 109.667 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -95.24 179.25 5.25 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 142' ' ' VAL . 53.5 t80 -59.95 -45.7 91.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 1.0 110.885 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -58.87 -46.28 88.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.469 -1.394 . . . . 1.0 109.949 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.55 -36.46 82.73 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.4 -0.812 . . . . 1.0 109.313 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.03 -43.53 98.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.408 -0.807 . . . . 1.0 109.089 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 138' ' ' TYR . 98.0 t -62.06 -51.0 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.102 -0.999 . . . . 1.0 109.443 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -59.28 -42.75 91.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.859 -1.15 . . . . 1.0 110.02 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . 0.547 ' SD ' ' SD ' ' A' ' 145' ' ' MET . 1.0 OUTLIER -65.58 -35.35 80.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 1.0 110.482 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.547 ' SD ' ' SD ' ' A' ' 144' ' ' MET . 71.7 mmm . . . . . 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 1.0 110.405 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.588 -0.523 . . . . 1.0 109.588 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.01 -39.79 93.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.637 -1.289 . . . . 1.0 109.05 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 57.8 mt-10 -61.61 -43.52 98.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.25 -0.906 . . . . 1.0 108.587 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.42 HG21 HG22 ' A' ' 142' ' ' VAL . 69.8 mt -69.27 -43.47 81.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.303 -0.873 . . . . 1.0 109.524 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' A' ' 86' ' ' ARG . 0.4 OUTLIER -65.08 -50.39 66.33 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 1.0 109.362 179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -58.26 -44.96 88.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.878 -1.139 . . . . 1.0 108.412 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.55 -41.61 97.62 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.327 -0.99 . . . . 1.0 108.327 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -62.9 -40.22 96.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.027 -1.045 . . . . 1.0 109.279 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.605 HH21 ' CA ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -69.72 -32.74 71.47 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.937 -1.102 . . . . 1.0 108.996 179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 40.2 t -65.46 -36.69 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.181 -0.949 . . . . 1.0 109.879 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' CE1' HG11 ' A' ' 108' ' ' VAL . 3.2 m-85 -79.76 -25.93 40.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.966 -1.084 . . . . 1.0 109.606 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 98' ' ' GLY . 53.8 t0 -79.74 74.26 6.44 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 1.0 108.556 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.489 ' HZ1' HG22 ' A' ' 108' ' ' VAL . 12.1 mptt -54.14 -38.74 65.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.873 -0.517 . . . . 1.0 110.798 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.455 ' OD1' ' N ' ' A' ' 97' ' ' ASN . 9.4 p30 -88.31 -4.9 58.61 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.121 -0.987 . . . . 1.0 110.952 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.605 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . 67.63 23.1 73.78 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.599 -1.286 . . . . 1.0 110.187 179.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.486 ' O ' ' CD2' ' A' ' 99' ' ' TYR . 50.5 p-10 -76.69 -3.06 36.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -1.14 . . . . 1.0 110.73 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.433 ' N ' ' OD2' ' A' ' 93' ' ' ASP . . . 79.34 5.17 89.24 Favored Glycine 0 N--CA 1.489 2.193 0 O-C-N 120.591 -1.318 . . . . 1.0 110.538 178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.486 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 31.3 m-85 -139.44 138.84 36.8 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.303 -1.116 . . . . 1.0 109.822 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.0 mt -96.31 122.24 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.39 -0.819 . . . . 1.0 109.06 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 16.6 t -84.78 158.97 20.55 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 121.509 0.671 . . . . 1.0 109.575 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -58.82 -44.71 90.92 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.342 -0.849 . . . . 1.0 109.698 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.429 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . . . -63.53 -33.65 76.06 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.144 -0.972 . . . . 1.0 109.274 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 74.2 mt-10 -65.48 -36.58 84.3 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.631 -1.248 . . . . 1.0 107.631 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 7.5 tp -63.62 -38.22 90.3 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.404 -0.961 . . . . 1.0 108.404 179.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.568 ' O ' HG23 ' A' ' 110' ' ' THR . 33.9 mtm180 -64.07 -36.2 83.23 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.167 -0.679 . . . . 1.0 109.167 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 43.7 t-80 -65.73 -50.51 64.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.289 -0.882 . . . . 1.0 109.267 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.489 HG22 ' HZ1' ' A' ' 94' ' ' LYS . 22.9 t -65.95 -47.43 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.958 . . . . 1.0 110.349 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.594 ' N ' ' SD ' ' A' ' 109' ' ' MET . 0.0 OUTLIER -65.98 -41.4 91.18 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.368 -0.833 . . . . 1.0 110.742 -178.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 106' ' ' ARG . 35.6 p -65.05 -45.75 84.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.116 -0.99 . . . . 1.0 110.619 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -76.68 -28.64 56.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.799 -1.188 . . . . 1.0 109.836 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 25.6 tp -68.33 -5.99 21.74 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 1.0 109.13 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 103.33 -5.76 49.31 Favored Glycine 0 N--CA 1.5 2.927 0 N-CA-C 110.103 -1.199 . . . . 1.0 110.103 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.492 ' O ' ' O ' ' A' ' 109' ' ' MET . 94.7 mt-10 -99.97 114.88 28.46 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.135 -1.215 . . . . 1.0 108.247 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -101.75 102.86 13.56 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.893 -1.13 . . . . 1.0 108.966 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 27.0 mt -104.36 148.13 26.74 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.698 0.761 . . . . 1.0 109.907 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 28.7 p -84.93 165.18 17.85 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.042 -1.096 . . . . 1.0 108.042 178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 80.0 m-20 -57.58 -31.94 66.67 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.868 -1.145 . . . . 1.0 109.678 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.1 tm-20 -74.84 -41.34 60.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.953 -1.092 . . . . 1.0 109.509 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -60.86 -38.01 84.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.088 -1.008 . . . . 1.0 108.76 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 66.8 t -72.55 -35.68 51.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 107.689 -1.226 . . . . 1.0 107.689 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.546 ' C ' ' HE ' ' A' ' 126' ' ' ARG . 46.8 t0 -57.78 -42.28 83.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.426 -1.324 . . . . 1.0 107.426 177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.538 ' CA ' HH21 ' A' ' 126' ' ' ARG . 84.4 tt0 -61.7 -46.61 88.96 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.164 -0.96 . . . . 1.0 109.195 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 77.5 mtp -64.67 -42.63 95.23 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.102 -0.999 . . . . 1.0 109.682 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.467 ' O ' ' N ' ' A' ' 129' ' ' ASP . 22.5 mm -65.37 -49.61 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.524 -0.735 . . . . 1.0 109.194 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.546 ' HE ' ' C ' ' A' ' 122' ' ' ASP . 87.6 mtm180 -61.03 -38.17 85.15 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.317 -0.864 . . . . 1.0 109.877 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -72.28 -42.37 65.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.037 -1.039 . . . . 1.0 109.567 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.85 -22.82 31.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.099 -1.0 . . . . 1.0 110.175 -179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 125' ' ' ILE . 43.8 t0 -81.08 101.56 9.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.142 -0.974 . . . . 1.0 109.16 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 97.4 mt -86.06 -28.07 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.598 -0.689 . . . . 1.0 110.475 -178.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 17.4 p30 -88.98 0.98 56.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.697 -1.252 . . . . 1.0 109.303 -179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 63.52 23.46 66.83 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.503 ' N ' ' OD1' ' A' ' 131' ' ' ASP . 28.7 p-10 -76.99 -15.81 59.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.027 -1.278 . . . . 1.0 109.471 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 89.44 10.46 65.6 Favored Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.596 -1.002 . . . . 1.0 110.596 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -140.97 160.35 40.26 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.109 -1.23 . . . . 1.0 109.427 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.8 t -102.73 123.05 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 121.229 -0.919 . . . . 1.0 109.908 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.551 HD21 ' CD ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -95.61 173.99 7.21 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.246 -1.02 . . . . 1.0 108.246 178.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.422 ' O ' HG23 ' A' ' 142' ' ' VAL . 86.1 t80 -55.39 -47.04 76.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.058 -1.027 . . . . 1.0 110.747 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.623 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 31.1 mp0 -60.05 -45.88 91.37 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.436 -1.415 . . . . 1.0 110.243 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.551 ' CD ' HD21 ' A' ' 137' ' ' ASN . 94.6 mt-10 -65.53 -39.28 91.59 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 1.0 109.769 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' SD ' ' A' ' 145' ' ' MET . 30.7 t80 -62.07 -44.3 96.97 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.205 -0.934 . . . . 1.0 109.265 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 146' ' ' THR . 96.3 t -59.66 -50.56 79.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.107 -0.996 . . . . 1.0 109.281 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -61.86 -42.4 99.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.018 -1.051 . . . . 1.0 110.352 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.472 ' C ' ' SD ' ' A' ' 144' ' ' MET . 1.1 tmt? -64.36 -41.5 96.7 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.953 -1.092 . . . . 1.0 110.448 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 141' ' ' PHE . 2.0 mpt? -91.01 -22.64 20.68 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.795 -1.19 . . . . 1.0 110.192 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.502 ' N ' ' O ' ' A' ' 142' ' ' VAL . 2.5 m -109.9 24.14 13.43 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 108.439 -0.948 . . . . 1.0 108.439 178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -54.69 91.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.029 -1.045 . . . . 1.0 109.301 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 146' ' ' THR . 4.9 tmtt? . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.175 -0.953 . . . . 1.0 109.166 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1000 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1001 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.712 0.768 . . . . 1.97 109.477 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -71.54 -36.01 70.84 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.667 -0.646 . . . . 2.2200000000000002 110.096 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -62.83 -54.25 41.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.883 -1.136 . . . . 2.2799999999999998 109.381 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.421 ' CG1' ' N ' ' A' ' 86' ' ' ARG . 6.4 pt -68.12 -43.51 85.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.152 -0.967 . . . . 0.29999999999999999 109.801 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.421 ' N ' ' CG1' ' A' ' 85' ' ' ILE . 65.3 ttt180 -65.13 -46.32 81.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.04 -1.037 . . . . 2.7200000000000002 109.737 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -57.24 -45.57 83.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.884 -1.135 . . . . 3.0499999999999998 108.388 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.513 ' O ' ' CD2' ' A' ' 92' ' ' PHE . . . -60.05 -41.38 92.19 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.011 -1.107 . . . . 0.070000000000000007 108.011 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -62.43 -39.93 94.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.121 -0.987 . . . . 0.11 109.31 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.604 ' CG ' HH11 ' A' ' 90' ' ' ARG . 0.0 OUTLIER -71.64 -34.53 69.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.94 -1.1 . . . . 4.6900000000000004 108.793 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.5 t -65.19 -38.33 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.215 -0.928 . . . . 0.11 109.44 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 88' ' ' ALA . 9.8 m-85 -78.11 -28.16 48.55 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.103 -0.998 . . . . 0.20999999999999999 109.239 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.544 ' OD1' ' ND2' ' A' ' 97' ' ' ASN . 57.6 t0 -79.19 75.69 5.74 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.059 -1.026 . . . . 1.46 108.464 178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -54.82 -38.21 67.08 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 116.055 -0.52 . . . . 3.98 111.438 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.424 ' OD1' ' OD1' ' A' ' 93' ' ' ASP . 20.0 p30 -89.92 -2.97 58.28 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.837 -1.164 . . . . 3.1000000000000001 110.857 -178.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.525 ' CA ' HH21 ' A' ' 90' ' ' ARG . . . 65.58 24.01 70.8 Favored Glycine 0 N--CA 1.493 2.463 0 C-N-CA 119.984 -1.103 . . . . 0.46000000000000002 111.031 178.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.819 ' ND2' ' H ' ' A' ' 99' ' ' TYR . 0.1 OUTLIER -79.54 1.19 26.77 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.08 -1.247 . . . . 1.3100000000000001 110.387 -179.314 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.627 ' N ' HD22 ' A' ' 97' ' ' ASN . . . 78.46 -0.68 74.69 Favored Glycine 0 N--CA 1.491 2.327 0 O-C-N 120.627 -1.296 . . . . 0.23000000000000001 110.911 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.819 ' H ' ' ND2' ' A' ' 97' ' ' ASN . 22.7 m-85 -135.26 141.0 45.65 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.417 -1.049 . . . . 0.81000000000000005 109.941 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.5 mt -100.57 127.38 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.415 -0.803 . . . . 0.31 109.363 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.3 p -87.46 160.0 18.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.738 . . . . 0.20999999999999999 109.322 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.09 -45.2 93.74 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.32 -0.863 . . . . 0.11 109.671 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.3 -33.08 74.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.158 -0.963 . . . . 0.12 108.952 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 86.2 mt-10 -66.46 -36.19 82.15 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 107.364 -1.347 . . . . 0.81000000000000005 107.364 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.0 tp -63.51 -34.44 77.79 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.607 -1.257 . . . . 0.16 107.607 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.513 ' NH1' ' OD1' ' A' ' 118' ' ' ASP . 61.3 ttt180 -67.6 -35.13 78.39 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.586 -0.697 . . . . 3.52 109.284 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -67.74 -53.13 29.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.359 -0.838 . . . . 0.48999999999999999 109.652 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.518 HG23 ' N ' ' A' ' 109' ' ' MET . 5.2 m -66.68 -45.65 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.96 -1.088 . . . . 0.10000000000000001 109.68 -178.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.518 ' N ' HG23 ' A' ' 108' ' ' VAL . 14.5 mmt -65.3 -39.52 92.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.136 -0.977 . . . . 0.12 110.257 -179.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.419 ' OG1' ' O ' ' A' ' 106' ' ' ARG . 53.0 m -65.68 -43.39 89.4 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.278 -0.889 . . . . 0.17999999999999999 110.525 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -79.72 -29.29 40.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.841 -1.162 . . . . 1.1200000000000001 110.253 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 18.7 mt -63.07 -1.74 1.06 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.95 -1.094 . . . . 0.45000000000000001 109.753 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.61 -8.52 60.1 Favored Glycine 0 N--CA 1.499 2.884 0 N-CA-C 110.079 -1.208 . . . . 0.40999999999999998 110.079 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.465 ' O ' ' O ' ' A' ' 109' ' ' MET . 94.2 mt-10 -94.88 120.03 34.42 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.089 -1.242 . . . . 2.29 108.119 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -105.8 100.05 9.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.126 -0.984 . . . . 1.51 109.06 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.1 mt -105.84 149.9 26.09 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.656 0.741 . . . . 3.77 109.857 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 30.9 p -83.0 166.13 19.07 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.261 -1.014 . . . . 0.29999999999999999 108.261 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.513 ' OD1' ' NH1' ' A' ' 106' ' ' ARG . 81.6 m-20 -58.12 -36.45 72.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.943 -1.098 . . . . 1.6000000000000001 109.855 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -71.01 -39.89 72.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.826 -1.171 . . . . 1.75 109.15 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.7 -38.48 91.15 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.465 -0.939 . . . . 0.68000000000000005 108.465 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 77.1 t -70.48 -47.88 62.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.17 -1.048 . . . . 0.44 108.17 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -52.22 -42.09 63.27 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 107.863 -1.162 . . . . 1.29 107.863 177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 14.7 tm-20 -56.78 -43.66 81.07 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.119 -0.988 . . . . 3.1899999999999999 108.666 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 5.3 mmt -63.28 -42.12 99.08 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.279 -0.888 . . . . 1.8100000000000001 110.274 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.507 ' O ' ' N ' ' A' ' 129' ' ' ASP . 2.7 mp -68.57 -44.06 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.044 -1.035 . . . . 0.089999999999999997 109.247 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 -61.87 -43.4 98.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.123 -0.986 . . . . 4.4199999999999999 110.066 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -66.08 -39.24 89.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.011 -1.056 . . . . 1.95 109.418 -179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.34 -20.07 27.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.208 -0.932 . . . . 0.11 110.458 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 125' ' ' ILE . 61.7 t0 -82.12 101.25 10.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.984 -1.073 . . . . 1.9299999999999999 109.293 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 98.4 mt -90.2 -28.94 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.723 -0.611 . . . . 0.45000000000000001 111.156 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 52.5 p30 -87.85 1.39 54.1 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.695 -1.253 . . . . 1.1499999999999999 109.797 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.33 76.69 0.22 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.786 -1.325 . . . . 1.1499999999999999 109.786 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 134' ' ' GLY . 37.8 p-10 -133.64 -14.58 2.49 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -1.097 . . . . 2.4900000000000002 108.625 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.432 ' N ' ' OD1' ' A' ' 133' ' ' ASP . . . 88.12 9.3 70.65 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.454 -1.058 . . . . 0.31 110.454 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -141.45 161.43 37.91 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.149 -1.206 . . . . 1.71 109.537 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 47.8 t -109.11 126.28 66.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 O-C-N 121.251 -0.906 . . . . 0.34999999999999998 110.209 -179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.548 HD21 ' CD ' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -97.21 177.52 5.54 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.551 -0.907 . . . . 2.4500000000000002 108.551 178.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -59.52 -47.04 87.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.15 -0.969 . . . . 1.1599999999999999 111.081 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -58.22 -46.26 86.2 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.314 -1.491 . . . . 2.8999999999999999 109.877 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.548 ' CD ' HD21 ' A' ' 137' ' ' ASN . 95.8 mt-10 -66.25 -39.06 89.23 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 2.77 109.674 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.585 ' CZ ' ' SD ' ' A' ' 145' ' ' MET . 34.5 t80 -61.34 -43.65 98.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.245 -0.909 . . . . 0.38 109.136 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 146' ' ' THR . 95.0 t -61.53 -50.59 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.393 -0.817 . . . . 0.40000000000000002 109.61 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -59.24 -41.78 89.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.749 -1.22 . . . . 1.5700000000000001 109.837 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.445 ' C ' ' SD ' ' A' ' 144' ' ' MET . 14.1 tmm? -67.38 -37.19 82.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.156 -0.965 . . . . 0.79000000000000004 110.575 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.585 ' SD ' ' CZ ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -93.17 -28.49 16.26 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.07 -1.019 . . . . 0.35999999999999999 110.919 -178.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 142' ' ' VAL . 38.6 m -52.56 -48.64 66.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.931 . . . . 0.81999999999999995 109.249 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 46.86 -140.64 0.49 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.281 -0.887 . . . . 1.28 109.747 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.421 ' HZ2' ' HB3' ' A' ' 148' ' ' LYS . 1.2 ptpp? . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 2.2599999999999998 109.463 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1000 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 1001 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.603 -0.517 . . . . 1.0 109.603 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -63.51 -36.91 85.34 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.931 -1.106 . . . . 1.0 108.213 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -65.99 -38.85 89.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.399 -0.813 . . . . 1.0 109.284 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 71.0 mt -62.99 -46.37 96.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.179 -0.951 . . . . 1.0 109.651 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -63.6 -45.69 89.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.028 . . . . 1.0 109.2 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.413 ' O ' HG23 ' A' ' 91' ' ' VAL . 83.0 tt0 -59.65 -46.57 88.63 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.904 -1.122 . . . . 1.0 108.789 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.65 -41.61 95.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.112 -0.992 . . . . 1.0 108.494 179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -62.55 -40.68 97.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.111 -0.993 . . . . 1.0 109.305 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -71.39 -34.09 70.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.995 -1.066 . . . . 1.0 109.214 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 87' ' ' GLU . 62.2 t -67.74 -33.62 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.029 . . . . 1.0 109.484 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 92' ' ' PHE . 4.4 m-30 -80.74 -28.2 36.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.904 -1.122 . . . . 1.0 108.743 179.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.507 ' OD2' ' N ' ' A' ' 97' ' ' ASN . 2.5 t70 -76.73 74.59 3.39 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.602 -1.258 . . . . 1.0 107.602 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 52.4 mmtt -55.04 -40.18 69.97 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.743 -0.662 . . . . 1.0 111.389 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.9 p30 -89.98 -1.55 57.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.919 -1.113 . . . . 1.0 110.519 -178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.38 22.02 70.87 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.885 -1.15 . . . . 1.0 110.306 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.507 ' N ' ' OD2' ' A' ' 93' ' ' ASP . 48.3 p-10 -75.67 -3.81 36.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -1.092 . . . . 1.0 110.249 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 79.41 7.85 88.19 Favored Glycine 0 N--CA 1.49 2.261 0 O-C-N 120.665 -1.272 . . . . 1.0 111.006 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 97' ' ' ASN . 45.9 m-85 -141.36 135.65 30.69 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.097 -1.237 . . . . 1.0 109.623 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 67.8 mt -93.31 125.78 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.222 -0.924 . . . . 1.0 109.399 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 11.0 t -90.26 158.8 17.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.485 -0.76 . . . . 1.0 109.377 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.465 ' HA ' HD11 ' A' ' 125' ' ' ILE . . . -56.87 -43.67 81.47 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.371 -0.831 . . . . 1.0 109.612 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.22 -32.65 74.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.155 -0.965 . . . . 1.0 109.254 179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -67.37 -38.56 84.94 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.85 -1.167 . . . . 1.0 107.85 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.9 tp -63.78 -34.36 77.74 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.913 -1.143 . . . . 1.0 107.913 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -66.97 -34.54 77.99 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.523 -0.735 . . . . 1.0 109.068 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -68.14 -53.64 23.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.317 -0.865 . . . . 1.0 109.811 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.486 HG23 ' N ' ' A' ' 109' ' ' MET . 3.1 m -65.61 -46.27 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.92 -1.113 . . . . 1.0 110.003 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.486 ' N ' HG23 ' A' ' 108' ' ' VAL . 14.2 mmt -65.69 -39.73 91.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 1.0 110.554 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.9 m -64.72 -45.47 86.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.236 -0.915 . . . . 1.0 110.752 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -76.39 -26.45 55.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.719 -1.238 . . . . 1.0 110.108 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 24.0 mt -68.52 -2.74 9.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.055 -1.028 . . . . 1.0 109.726 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.71 -5.77 56.91 Favored Glycine 0 N--CA 1.499 2.876 0 N-CA-C 110.118 -1.193 . . . . 1.0 110.118 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.484 ' O ' ' O ' ' A' ' 109' ' ' MET . 70.1 mm-40 -102.05 115.44 30.55 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.231 -1.158 . . . . 1.0 108.044 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.425 ' C ' HD12 ' A' ' 116' ' ' LEU . 37.9 tptt -101.54 105.51 16.49 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.87 -1.144 . . . . 1.0 109.16 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.56 ' N ' HD12 ' A' ' 116' ' ' LEU . 10.0 mp -102.73 145.23 30.03 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.608 -0.682 . . . . 1.0 109.403 -179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.6 p -81.07 166.21 20.94 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.719 -1.215 . . . . 1.0 107.719 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -57.49 -34.31 68.94 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.864 -1.147 . . . . 1.0 109.475 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 119' ' ' GLU . 42.0 mp0 -74.39 -39.48 62.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.938 -1.101 . . . . 1.0 109.178 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -62.71 -38.66 91.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -0.95 . . . . 1.0 108.678 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.9 t -71.71 -36.51 59.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 107.566 -1.272 . . . . 1.0 107.566 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.3 -44.86 92.48 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.538 -1.282 . . . . 1.0 107.538 177.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.427 ' O ' ' OE2' ' A' ' 127' ' ' GLU . 85.8 tt0 -56.85 -46.75 81.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 1.0 108.959 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 49.0 mtt -65.02 -41.42 95.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 1.0 109.744 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 129' ' ' ASP . 5.8 mm -66.1 -48.5 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.4 -0.812 . . . . 1.0 109.843 -179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 15.7 mmt180 -62.09 -39.73 93.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 1.0 109.939 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.527 ' N ' ' OE1' ' A' ' 127' ' ' GLU . 0.2 OUTLIER -69.39 -40.25 77.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.001 -1.062 . . . . 1.0 109.27 -179.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.24 -21.76 28.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.07 -1.019 . . . . 1.0 110.257 -179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 125' ' ' ILE . 33.2 t0 -82.72 103.54 12.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.118 -0.989 . . . . 1.0 109.158 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 98.5 mt -87.99 -28.63 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.502 -0.749 . . . . 1.0 111.024 -178.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 47.5 p30 -87.68 2.79 50.1 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.546 -1.346 . . . . 1.0 109.573 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 60.64 18.26 51.52 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.163 -1.175 . . . . 1.0 110.163 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.429 ' OD1' ' OD1' ' A' ' 129' ' ' ASP . 23.2 p-10 -71.57 -11.49 60.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.938 -1.331 . . . . 1.0 109.162 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 87.5 6.44 77.4 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 110.281 -1.128 . . . . 1.0 110.281 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -140.11 163.55 32.42 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.24 -1.153 . . . . 1.0 109.222 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.6 t -112.02 124.18 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 O-C-N 121.297 -0.877 . . . . 1.0 109.667 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -95.24 179.25 5.25 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.61 -0.885 . . . . 1.0 108.61 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.402 ' O ' HG23 ' A' ' 142' ' ' VAL . 53.5 t80 -59.95 -45.7 91.81 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.121 -0.987 . . . . 1.0 110.885 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -58.87 -46.28 88.17 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.469 -1.394 . . . . 1.0 109.949 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.55 -36.46 82.73 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.4 -0.812 . . . . 1.0 109.313 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -63.03 -43.53 98.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.408 -0.807 . . . . 1.0 109.089 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 146' ' ' THR . 98.0 t -62.06 -51.0 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.102 -0.999 . . . . 1.0 109.443 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -59.28 -42.75 91.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.859 -1.15 . . . . 1.0 110.02 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . 0.547 ' SD ' ' SD ' ' A' ' 145' ' ' MET . 1.0 OUTLIER -65.58 -35.35 80.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.226 -0.921 . . . . 1.0 110.482 -179.215 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.547 ' SD ' ' SD ' ' A' ' 144' ' ' MET . 71.7 mmm -93.03 -25.16 18.07 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.132 -0.98 . . . . 1.0 110.405 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.498 ' N ' ' O ' ' A' ' 142' ' ' VAL . 27.1 p -113.74 25.54 11.13 Favored 'General case' 0 N--CA 1.501 2.087 0 N-CA-C 108.858 -0.793 . . . . 1.0 108.858 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -52.13 140.27 21.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.063 -1.023 . . . . 1.0 109.244 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 57.7 mttp . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.145 -0.972 . . . . 1.0 109.482 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1000 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 1001 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_